0000000000975800

AUTHOR

Gaspare Parrinello

showing 155 related works from this author

Fever of Unclear Origin and Cytopenia Because of Acute Splenic Sequestration in a Young Immunocompetent Carrier of Beta-Globin Mutation for Hb Vallet…

2008

Fever of unclear origin is a clinical challenge in medical practice. Infectious diseases, neoplasms, and collagen vascular illnesses are its main causes in adults and children. Acute splenic sequestration crises, a known potentially fatal complication of sickle cell disease and sickle beta-thalassemia, are uncommon in beta-heterozygosis. We describe a case of prolonged recurrent episodes of fever with spontaneous resolution, commencing at age 10 in a 15-year-old boy with a history of hypochromic microcytic anemia attributed to a thalassemic trait. He was admitted twice to our university hospital for continuous-remittent fever with a pruritic, macular evanescent Still's skin rash, severe spl…

AdultMaleAdolescentFeverAnemiaHemoglobins AbnormalThalassemiaHepatosplenomegalybeta-Globinshemic and lymphatic diseasesmedicineHumansChildCytopeniabusiness.industryBeta thalassemiaAnemiaGeneral Medicinemedicine.diseaseHematologic DiseasesHypochromic microcytic anemiaHemoglobinopathyMutationImmunologymedicine.symptomSplenic diseasebusinessImmunocompetenceSpleenThe American Journal of the Medical Sciences
researchProduct

Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities.

2019

BACKGROUND: It has been reported that changes in cardiac structure and ventricular function associated with obesity have to be attributable to hemodynamic and non-hemodynamic alterations. Accordingly, the aim of this was to evaluate left ventricular hypertrophy (LVH) prevalence and its effect on left ventricular systolic and diastolic function in a cohort of obese patients. MATERIALS AND METHODS: LV internal diameter (LVID), left ventricular mass (LVM) and LVM/height2.7(LVMI), relative wall thickness (RWT), LV ejection fraction (LVEF), E/A ratio, isovolumic relaxation time, deceleration time of E velocity by echocardiography and pulsed-wave Doppler and total circulating adiponectin (ADPN) b…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart VentriclesHemodynamics030204 cardiovascular system & hematologyLeft ventricular hypertrophy03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineWaist–hip ratioobesity cardiac structureInternal medicinemedicineHumansCardiac structure030212 general & internal medicineObesityPhenomicsskin and connective tissue diseasesCorrelation of DataEchocardiography Doppler PulsedAdiponectinbusiness.industryCardiometabolic Risk FactorsStroke VolumeGeneral MedicineOrgan SizeMiddle Agedmedicine.diseaseObesityBlood pressureItalyEchocardiographycardiovascular systemCardiologyFemaleHypertrophy Left Ventricularsense organsAdiponectinCardiology and Cardiovascular MedicinebusinessFunction (biology)Acta cardiologica
researchProduct

Clinical-anamnestic and instrumental data in outpatients suffering from venous disease

1995

The authors studied 200 consecutive outpatients with symptoms due to venous disease of the lower limbs. All the patients underwent anamnestic, clinical and instrumental evaluation (c.w. Doppler velocimetry and strain-gauge plethysmography). The results of this study showed that some anamnestic and clinical data are significantly related to venous disease detected by instrumental techniques. The superficial and deep vein hypertension were, instead, correlated to oral contraceptive use.

AdultAged 80 and overMaleLegSettore MED/09 - Medicina InternaAdolescentMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolarePlethysmographyAdolescent Adult Aged Aged 80 and over Blood Flow Velocity Contraceptives Oral/adverse effects Female Humans Hypertension/chemically induced Laser-Doppler Flowmetry Leg/blood supply Male Medical History Taking Middle Aged Morbidity Outpatients* Phlebitis/diagnosis Phlebitis/epidemiology Phlebitis/etiology* Plethysmography Pregnancy Retrospective Studies Risk FactorsPregnancyRisk FactorsHypertensionOutpatientsLaser-Doppler FlowmetryHumansFemaleMorbidityMedical History TakingPhlebitisBlood Flow VelocityAgedContraceptives OralRetrospective Studies
researchProduct

One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.

2009

BACKGROUND AND OBJECTIVES: Hypertension is a significant cause of chronic renal injury and its effective treatment is capable of reducing the rate of renal failure. beta-Adrenoceptor antagonists (beta-blockers) have been reported to induce a deterioration in renal function, while several data have indicated a renoprotective effect of treatment with the angiotensin II type 1 receptor antagonist losartan. Previous studies of the interaction between the selective beta(1)-blocker bisoprolol and kidney function were performed only for short- and medium-term periods. The aim of this study was to compare the antihypertensive efficacy and renal and cardiac haemodynamic effects of bisoprolol with th…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.drug_classRenal functionHemodynamicsEssential hypertensionKidneyKidney Function TestsLosartanlaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineBisoprololHumansPharmacology (medical)Antihypertensive Agentshypertension losartanbisiprololbusiness.industryHeartGeneral MedicineMiddle AgedReceptor antagonistmedicine.diseaseAngiotensin IILosartanBisoprololHeart Function TestsHypertensionCardiologyFemalebusinessmedicine.drug
researchProduct

Angiotensin converting enzyme gene polimorfism and central obesity: relationship with blood pressure and left ventricular structure and function

2001

medicine.medical_specialtyEjection fractionMegalencephalic leukoencephalopathy with subcortical cystsbiologybusiness.industryDiastoleAngiotensin-converting enzymemedicine.diseaseInappropriate sinus tachycardiaBlood pressureWaist–hip ratioEndocrinologyInternal medicineInternal Medicinemedicinebiology.proteinCardiologySystolebusinessAmerican Journal of Hypertension
researchProduct

Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study

2008

Abstract Background Nitric oxide (NO) synthesized by endothelial nitric oxide synthase (eNOS) plays an important role in regulation of endothelial function and in the control of blood pressure. However, the results from some studies on the association between three clinically relevant eNOS gene polymorphisms (G894T, T786C and intron 4b/a) and essential hypertension are unclear. We designed a case-control study to evaluate the influence of eNOS polymorphisms on target organ damage in 127 hypertensives and 67 normotensives. Clinical evaluation, biochemical parameters, Urinary Albumin Excretion (UAE) and echocardiogram were performed to characterize target organ damage. eNOS polymorphism were …

lcsh:Immunologic diseases. AllergyAgingmedicine.medical_specialtyPopulationImmunologyClinical nutritionlcsh:GeriatricsBioinformaticsEssential hypertensionNitric oxidechemistry.chemical_compoundEnosInternal medicinemedicineeducationeducation.field_of_studybiologybusiness.industryResearchCase-control studybiology.organism_classificationmedicine.diseaseAgeinglcsh:RC952-954.6Blood pressureEndocrinologychemistrybusinesslcsh:RC581-607Body mass indexImmunity & ageing : I & A
researchProduct

Small-volume hypertonic saline solution and high-dosage furosemide in the treatment of refractory congestive heart failure. A pilot study

2000

Objective: To evaluate a new therapeutic approach to hospitalised patients with refractory congestive heart failure (CHF) based on published data on the efficacy of furosemide (frusemide) intravenous infusion in refractory CHF and of small volumes of hypertonic saline solution in the low-flow state. Design and Setting: Prospective, uncontrolled study of hospital inpatients. Study Participants and Interventions: Thirty patients (20 males and 10 females) aged 65 to 85 years with refractory New York Heart Association (NYHA) functional class IV CHF were given a twice-daily intravenous infusion of a small volume of hypertonic saline solution (150 ml of 1.4 to 4.6 NaCl) containing high-dosage fur…

Pharmacologymedicine.medical_specialtySmall volumebusiness.industryHypertonic Saline SolutionFurosemideGeneral Medicinemedicine.diseaseRefractoryAtrial natriuretic peptideHigh dosageAnesthesiaRenal blood flowInternal medicineHeart failuremedicineCardiologyPharmacology (medical)cardiovascular diseasesbusinessmedicine.drugPharmacology (medical); Pharmacology
researchProduct

Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity.

1992

The present study was carried out to evaluate systolic and diastolic parameters in overweight and moderately obese, but otherwise healthy subjects, and in a lean control group, to determine whether degree and duration of obesity can influence left ventricular function. A total of 27 subjects, 17 overweight or with moderate obesity and 10 lean, healthy subjects were included. Patients were divided into three groups according to their body mass index (BMI) and to Garrow's criteria as follows: lean control group (BMI less than 25 kg.m-2); overweight subjects (BMI from 25 to 30 kg.m-2); moderately obese subjects (BMI greater than 30 less than 40 kg.m-2). Systolic and diastolic parameters were m…

Malemedicine.medical_specialtyMean arterial pressureSettore MED/09 - Medicina InternaTime FactorsSystoleDiastoleBlood PressureOverweightVentricular Function LeftRadionuclide angiographyDiastoleInternal medicinemedicineHumansObesitySystoleEjection fractionmedicine.diagnostic_testbusiness.industryBody WeightInfant Newbornnutritional and metabolic diseasesStroke VolumeStroke volumeMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyLeft ventricular function Systolic function diastolic function peak filling rate obesity radionuclide angiography.CardiologyRegression AnalysisFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexEuropean heart journal
researchProduct

Is there any novelty on the horizon of heart failure management in internal medicine? The evaluation of body fluid accumulation

2009

Heart Failureheart failure management body fluidBody fluidmedicine.medical_specialtybusiness.industryNoveltymedicine.diseaseBody FluidsDiagnosis DifferentialHeart failureEmergency MedicineInternal MedicinemedicineHumansMedical emergencybusinessIntensive care medicineInternal and Emergency Medicine
researchProduct

Is there a link between liver steatosis, carotid atherosclerosis and C-reactive protein in metabolic and non-metabolic patients?

2008

Carotid atherosclerosismedicine.medical_specialtybiologybusiness.industryC-reactive proteinGeneral MedicineEndocrinologyLiver steatosisInternal medicineInternal Medicinemedicinebiology.proteinCardiology and Cardiovascular Medicinebusiness
researchProduct

Treatment of Congestive Heart Failure in the Elderly

1998

Congestive heart failure (CHF) is a complex clinical syndrome which constitutes the epilogue of the natural history of virtually all heart diseases and in its advanced stages, has a poor prognosis. In the elderly, heart failure exhibits particular characteristics linked to the age-related alterations of cardiovascular system, to the association with other pathologies, to the atypical clinical presentation and to the increased iatrogenic risk. Heart failure now afflicts over 1% of the general population with nearly 1 in 10 elderly subjects affected, and the frequency of CHF is progressively increasing in most industrialized societies1,2. Further, CHF remains a significant cause of death and …

medicine.medical_specialtyeducation.field_of_studyPoor prognosisbusiness.industryAdvanced stagePopulationmedicine.diseaseNatural historyInternal medicineHeart failureCardiologyMedicineIsosorbide dinitratebusinesseducationClinical syndromeCause of deathmedicine.drug
researchProduct

452 Effects of a normosodic versus hyposodic diet in compensated congestive heart failure

2007

medicine.medical_specialtybusiness.industryInternal medicineHeart failuremedicineCardiologyCardiology and Cardiovascular Medicinemedicine.diseasebusinessEuropean Journal of Heart Failure Supplements
researchProduct

Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.

2011

Several studies have shown the efficacy of hypertonic saline solution infusion in conditions in which regional organ blood flow is impaired. Our group has shown that treatment of patients with diuretic-resistant heart failure with high-dose furosemide plus hypertonic saline is effective and well tolerated, improving symptoms of congestion, reducing plasma levels of markers of neurohormonal and inflammatory activation, decreasing hospital readmission rates, and reducing long-term mortality. The same regimen was shown to be better than repeated paracentesis in patients with cirrhosis and refractory ascites, yielding better control of ascites, pleural effusions, and/or leg edema without an inc…

Liver CirrhosisCirrhosisFurosemideAscitesmedicineParacentesisHumansAdverse effectDiureticsInfusions IntravenousHepatic encephalopathyHeart FailureSaline Solution Hypertonicmedicine.diagnostic_testCardio-Renal Syndromebusiness.industryFurosemideAscitesmedicine.diseaseHypertonic salineNephrologyAnesthesiaHeart failuremedicine.symptombusinessmedicine.drugSeminars in nephrology
researchProduct

evaluation of BNP plasma levels and bioelectrical impedance analysis (BIA) in decompensated heart failure. A double blind study

2005

medicine.medical_specialtyEjection fractionbusiness.industryFurosemidePlasma levelsmedicine.diseaseDouble blind studyFluid intakeHeart failureInternal medicineHeart rateInternal MedicineCardiologyMedicinebusinessBioelectrical impedance analysismedicine.drug
researchProduct

Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-H…

2012

Background High values of cardiac troponin in acute decompensated congestive heart failure (ADHF) identify patients at higher risk and worsened prognosis. A cardiac troponin increase during therapy indicates the need for more appropriate intervention, aimed at compensating cardiac disease and effectively minimizing myocardial wall stress and subsequent cytolysis. This study evaluated the effects of an intravenous high dose of furosemide with (group A) or without small volume hypertonic saline solution (HSS) (group B) on myocardial cytolysis in patients with ADHF. Methods A total of 248 consecutive patients with ADHF (148 men, mean age 74.9 ± 10.9 years) were randomly assigned to group A or …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHemodynamicsRenal functionDouble-Blind MethodFurosemideInternal medicineTroponin INatriuretic Peptide BrainmedicineElectric ImpedanceHumansPulmonary wedge pressureDiureticsAgedAged 80 and overHeart FailureSaline Solution Hypertonicbusiness.industryTroponin IFurosemideTRoponin I Heart Failure Hypertonic saline furosemideMiddle AgedBrain natriuretic peptidemedicine.diseaseSurgeryEchocardiography Doppler ColorHeart failureCardiologyPotassiumAdministration IntravenousDrug Therapy CombinationFemaleCardiology and Cardiovascular MedicinebusinessBioelectrical impedance analysismedicine.drug
researchProduct

Is losartan able to improve renal haemodynamics in hypertensives? a long term study

2000

medicine.medical_specialtyKidneybusiness.industryHemodynamicsRenal functionRenal haemodynamicsLosartanmedicine.anatomical_structureBlood pressureRenal blood flowInternal medicineInternal MedicineCardiologyVascular resistanceMedicinebusinessmedicine.drugAmerican Journal of Hypertension
researchProduct

Diastolic dysfunction and central obesity related hypertension: role of trasforming growth factor beta-1

2004

Abstract P-368 Key Words: Diastolic Dysfunction, Obesity Related Hypertension, Trasforming Growth Factor beta-1

medicine.medical_specialtySettore MED/09 - Medicina InternaMegalencephalic leukoencephalopathy with subcortical cystsmedicine.medical_treatmentDiastoleSettore MED/10 - Malattie Dell'Apparato RespiratorioOverweightLeft ventricular hypertrophyInternal medicineInternal MedicinemedicineSystolebiologybusiness.industryGrowth factorDiastolic Dysfunction Obesity Related Hypertension Trasforming Growth Factor beta-1Transforming growth factor betaDiastolic dysfunction HypertensionTrasforming factor beta 1medicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareObesityEndocrinologybiology.proteinCardiologymedicine.symptombusinessAmerican Journal of Hypertension
researchProduct

Salvage treatment with ganciclovir in a splenectomized, polytransfused patient affected by systemic inflammatory response syndrome

2014

A 23-year-old man was admitted to hospital with a 12-day history of daily fever. A clinical history revealed that 10 months previously, the patient had been splenectomized and polytransfused for a severe blunt trauma. On admission, laboratory data revealed significant leukocytosis (33,230/ul). The patient's general clinical conditions rapidly worsened into a severe systemic inflammatory response syndrome in four days. After 10 days of broad-spectrum antibiotic treatment, the temperature curve was unmodified and severe leukocytosis persisted (44,300 ul) with absolute lymphocytosis. Laboratory tests ruled out hematological diseases, pneumonia, abscesses and endocarditis. In the light of IgM …

PharmacologyGanciclovirmedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.drug_classbusiness.industryImmunologyAntibioticsSalvage treatmentmedicine.diseaseGastroenterologySystemic inflammatory response syndromePneumoniaBlunt traumaInternal medicineAnesthesiamedicineImmunology and AllergyEndocarditisganciclovirinflammatory responseLeukocytosismedicine.symptombusinessmedicine.drug
researchProduct

Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subj…

1994

This study was designed to evaluate the role of fasting serum insulin and plasma renin activity in obesity-induced hypertension. In view of this, plasma catecholamines, fasting serum insulin (IRI), urinary sodium excretion (NaU), plasma renin activity (PRA), and plasma aldosterone (PA) levels were assessed in young (age less than 40 years) normotensive (n = 27) and hypertensive (n = 14) subjects with central obesity and in lean normotensives (n = 20). Central obesity was evaluated by waist-to-hip ratio (WHR) according to the indication of the Italian Consensus Conference of Obesity. PRA, PA, IRI, and plasma norepinephrine levels were significantly (P < .05) higher in both obese groups than …

AdultMalemedicine.medical_specialtyCentral obesityHypertension Insulin Renin-angiotensin-aldosterone systemSettore MED/09 - Medicina Internamedicine.medical_treatmentBlood Pressureurologic and male genital diseasesPlasma renin activitySettore MED/13 - Endocrinologiachemistry.chemical_compoundDiastoleReference ValuesInternal medicineRenin–angiotensin systemBlood plasmaReninInternal MedicinemedicineHumansInsulinObesityAldosteronebusiness.industryInsulinFastingmedicine.diseaseObesitySettore MED/11 - Malattie Dell'Apparato Cardiovascolarefemale genital diseases and pregnancy complicationsEndocrinologyBlood pressurechemistryHypertensionFemalebusinessBody mass index
researchProduct

Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction

2015

Renal dysfunction (RD) and venous congestion are related and common in heart failure (HF). Studies suggest that venous congestion may be the primary driver of RD in HF. In this study, we sought to investigate retrospectively the relationship between common measures of renal function with caval congestion and mortality among outpatients with HF and RD. We reviewed data from 103 HF outpatients (45 males, mean age 74 years, ejection fraction 41.8 ± 11.6 %) with estimated glomerular filtration rate (eGFR) of 25.5 (adjusted OR 2.98, p 0.015) and eGFR ≤45.8 (adjusted OR 5.38, p 0.002) identify patients at risk for caval congestion; a BUN/Cr >23.7 was the best predictor of impaired collapsibility …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaRenal functionHyperemiaVena Cava InferiorHeart failureInferior vena cavaNyha classBlood Urea NitrogenCollapse index; Congestion; Heart failure; Inferior vena cava; Outpatients; Renal dysfunctionchemistry.chemical_compoundRisk FactorsInternal medicineInternal MedicinemedicineHumansRenal InsufficiencyInferior vena cavaBlood urea nitrogenAgedRetrospective StudiesCreatinineEjection fractionbusiness.industryOutpatientRetrospective cohort studymedicine.diseaseItalymedicine.veinchemistryCreatinineHeart failureCongestionEmergency MedicineCardiologyRenal dysfunctionFemaleCollapse indexbusinessBiomarkersGlomerular Filtration RateInternal and Emergency Medicine
researchProduct

Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline …

2005

OBJECTIVES: The aim of this study was to evaluate the effect of a new treatment for refractory congestive heart failure (CHF) on brain natriuretic peptide (BNP) plasma levels and hydration station. BACKGROUND: The study was aimed at evaluating the effects of the combination of high-dose furosemide and small-volume hypertonic saline solution (HSS) in refractory CHF patients. METHODS: A total of 94 patients (34 women/60 men) with refractory CHF (age 55 to 80 years) were enrolled. They had to have an ejection fraction &lt;35%, serum creatinine &lt;2 mg/dl, blood urea nitrogen &lt;60 mg/dl, a reduced urinary volume, and a low natriuresis (&lt;500 ml/24 h and &lt;60 mEq/24 h, respectively). Pati…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_classNatriuresisDouble-Blind MethodFurosemideHeart rateNatriuretic Peptide BrainNatriuretic peptidemedicineElectric ImpedanceHumansDiureticsBlood urea nitrogenAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionDose-Response Relationship Drugbusiness.industryBioelectrical ImpedanceBrain Natriuretic peptideFurosemideMiddle Agedmedicine.diseaseBrain natriuretic peptideSurgeryHeart failureAnesthesiaDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugFollow-Up StudiesJournal of the American College of Cardiology
researchProduct

Evaluation of regional haemodynamic and alterations of vascular wall of the lower limbs in hypertensive subjects.

1995

Vascular wallmedicine.medical_specialtybusiness.industryInternal medicineInternal MedicineCardiologyMedicineHemodynamicsbusinessAmerican Journal of Hypertension
researchProduct

Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compe…

2011

INTRODUCTION: Hypertonic saline solution (HSS) and a moderate Na restriction plus high furosemide dose showed beneficial effects in compensated heart failure (HF), in short and long terms. The study was aimed to verify the effects of this combination on hospitalization time, readmissions and mortality in patients in New York Heart Association (NYHA) class III. METHOD: Chronic ischemic or nonischemic cardiomyopathy uncompensated patients with HF in NYHA III functional class with ejection fraction <40%, serum creatinine <2.5 mg/dL, blood urea nitrogen <60 mg/dL and reduced urinary volume were single-blind randomized in 2 groups: the first group received a 30-minute intravenous infusion of fur…

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentDiuresisPatient ReadmissionFurosemideInternal medicinemedicineHumansInfusions IntravenousAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionbusiness.industrySodiumFurosemideGeneral MedicineDiet Sodium-RestrictedMiddle Agedmedicine.diseaseHyepertonic saline heart failure diureticsDiuresisSurgeryHospitalizationTreatment OutcomeHeart failureCirculatory systemCardiologyTonicityFemaleDiureticbusinessmedicine.drugThe American Journal of the Medical Sciences
researchProduct

BIOELECTRICAL IMPEDANCE ANALYSIS FOR PREDICTION OF HOSPITAL ADMISSION DUE TO CARDIAC DECOMPENSATION IN AMBULATORY HEART FAILURE: A FOLLOW-UP STUDY

2008

medicine.medical_specialtyCardiac decompensationbusiness.industryHeart failureHospital admissionAmbulatoryInternal MedicineFollow up studiesmedicineIntensive care medicinebusinessmedicine.diseaseBioelectrical impedance analysisEuropean Journal of Internal Medicine
researchProduct

Short-term walking physical training and changes in body hydration status, B-type natriuretic peptide and C-reactive protein levels in compensated co…

2008

BACKGROUND: Congestive heart failure (CHF) is associated with decreased exercise tolerance, alterations in body fluid balance and activation of neurohumoral and inflammatory pathways. Physical training, despite the contraindications of the past, is recommended for its beneficial effects on exercise capacity and quality of life. We investigate the effects of a short-term (ten weeks) walking physical training program (PT) on body hydration state (HS), B-type natriuretic peptide (BNP) and C-reactive protein (CRP) levels. METHODS AND RESULTS: 22 patients with CHF (mean age 62.7+/-4.8 years, 15 men, mean ejection fraction 38.9+/-3.6%, NYHA class II-III), were enrolled. Eleven patients were rando…

Congestive heart failureWalking physical training programMalemedicine.medical_specialtyHeart diseasemedicine.drug_classWalkingBody WaterInternal medicinemedicineNatriuretic peptideElectric ImpedanceHumansBody fluidHeart FailureEjection fractionExercise Tolerancebiologybusiness.industryC-reactive proteinAcute-phase proteinNatriuretic Peptide C-TypeMiddle Agedmedicine.diseaseExercise TherapyEndocrinologyC-Reactive ProteinB-type natriuretic peptideHeart failureBioelectrical impedance analysiCardiologybiology.proteinFemaleCardiology and Cardiovascular MedicinebusinessBioelectrical impedance analysisInternational journal of cardiology
researchProduct

Obesity and iron deficiency anemia as risk factors for asymptomatic bacteriuria.

2013

Background: Few studies examined the risk factors of asymptomatic bacteriuria, showing contradictory results. Our study aimed to examine the association between different clinical and laboratory parameters and asymptomatic bacteriuria in internal medicine patients. Materials and methods: 330 consecutive hospitalized subjects, asymptomatic for urinary tract infections (UTIs), underwent to microscopic examination of urine specimens. 100 subjects were positive for microscopic bacteriuria and were recruited into the study. At the quantitative urine culture 31 subjects of study population were positive while 69 subjects were negative for bacteriuria. Results: The analysis of clinical characteris…

Malemedicine.medical_specialtyBacteriuriaAnemiaUrinary systemUrineBacteriuriaurologic and male genital diseasesAsymptomaticRisk FactorsInternal medicineInternal MedicinemedicineHumansObesityAsymptomatic InfectionsAgedAnemia Iron-Deficiencybusiness.industryobesity anemia asymptomatic bacteriuriaOdds ratiobacterial infections and mycosesmedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryIron-deficiency anemiaPopulation studyFemalemedicine.symptombusinessEuropean journal of internal medicine
researchProduct

Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics an…

2020

Background: Different studies have indicated that thiazide diuretics can increase the risk of developing type 2 diabetes (T2D). Therefore, in this study, we investigated whether switching from hydrochlorothiazide (HCTZ) to amlodipine resulted in ameliorating different cardiovascular and metabolic measures in hypertensive patients with or without T2D. Methods: This study [Diuretics and Diabetes Control (DiaDiC)] was a 6-week, single-blind, single-center randomized controlled trial. The first 20 normal glucose-tolerant, 20 prediabetic, and 20 T2D consecutive patients were randomized to continue the previous antihypertensive treatment with HCTZ (12.5-25 mg/day) or to switch from HCTZ to amlodi…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismSodium Chloride Symporter InhibitorsdiureticBlood PressureType 2 diabetesSettore MED/13 - EndocrinologiaInternal medicineInternal MedicineMedicineHumansSingle-Blind MethodAmlodipineSettore MED/49 - Scienze Tecniche Dietetiche ApplicateThiazideAntihypertensive AgentsAgedtreatmentbusiness.industryDrug Substitutioncardiovascularfood and beveragesMiddle Agedmedicine.diseaseCalcium Channel BlockersDiabetes controlHydrochlorothiazideTreatment OutcomeDiabetes Mellitus Type 2ItalyHypertensionCardiologyFemaletype 2 diabetesAmlodipinethiazidebusinessEnergy MetabolismmetabolismBiomarkersmedicine.drugMetabolic syndrome and related disorders
researchProduct

Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment

2011

Propafenone is a membrane-stabilizing agent belonging to a subgroup of the Vaughan Williams class I antidysrhythmic agents, structurally resembling propranolol and characterized by weaker beta-blocking activity. Despite respiratory complications having been reported as examples of side effects, very few reports have been published in the literature.We describe the case of an elderly woman with a history of hypertension and allergy to Parietaria, grass, olive, mites, and with periodic asthmatic manifestations, for whom the administration of oral propafenone for recurrent supraventricular dysrhythmia was associated with the sudden onset of severe bronchostenosis.A 78-year-old woman was freque…

Pharmacologybusiness.industryGeneral MedicinePropafenonemedicine.diseaseRhonchipropafenone broncostenosisHypoxemiaBronchospasmAnesthesiamedicineSalbutamolPharmacology (medical)Medical historyRespiratory functionSupraventricular tachycardiamedicine.symptombusinessmedicine.drugAmerican Journal of Therapeutics
researchProduct

Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: Randomized control…

1992

In this study antihypertensive efficacy, safety, and the effects of short-term nitrendipine administration on central and renal hemodynamics were evaluated in mild to moderate hypertensives. Our final goal was to ascertain whether the reduction in blood pressure induced by nitrendipine treatment was associated with maintained renal function. After a run-in period with placebo, 26 hypertensives without cardiac or renal disease were randomly assigned to a double-blind 8-week controlled trial with nitrendipine (N) 20 mg once a day (13 pts) or hydrochlorothiazide (HCT) 25 mg once a day (13 pts). Renal hemodynamic measurements included effective renal plasma flow (ERPF) and glomerular filtration…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaHemodynamicsRenal functionKidneyHydrochlorothiazideDouble-Blind MethodNitrendipineInternal medicinemedicineHumansPharmacology (medical)PharmacologyEjection fractionbusiness.industryNitrendipineHemodynamicsGeneral MedicineEffective renal plasma flowMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareFiltration fractionHydrochlorothiazideEndocrinologyRenal blood flowHypertensionSettore BIO/14 - FarmacologiaCardiologyFemaleCalcium channel blockers nitrendipine essential arterial hypertension cardiac function renal function.Cardiology and Cardiovascular Medicinebusinessmedicine.drugCardiovascular Drugs and Therapy
researchProduct

Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic f…

2004

Background Aldosterone (ALDO) exerts profibrotic effects, acting via the mineralocorticoid receptors in cardiovascular tissues. Aldosterone antagonism in combination with angiotensin-converting enzyme inhibition may better protect against the untoward effects of ALDO than angiotensin-converting enzyme inhibition alone. Methods In a double-blind randomized study, the tolerability and efficacy of canrenoate (25 mg/d) plus captopril versus captopril alone were evaluated in 510 patients with an acute anterior myocardial infarction (MI), a serum creatinine concentration 5.5 mEq/L and creatinine levels to >2.0 mg/L after 10 days of treatment were observed. At 180 days, the mitral E-wave–A-wave ra…

Malemedicine.medical_specialtyAngiotensin-Converting Enzyme Inhibitors Mineralocorticoid Receptor Antagonists/administration & dosage Myocardial Contraction/drug effects Myocardial Infarction/drug therapy Myocardial Infarction/physiopathologymedicine.drug_classMyocardial InfarctionDiastoleAngiotensin-Converting Enzyme InhibitorsPlacebochemistry.chemical_compoundDouble-Blind MethodInternal medicinemedicineHumansMineralocorticoid Receptor AntagonistsCreatinineAldosteronebiologybusiness.industryCaptoprilAngiotensin-converting enzymeMiddle AgedMyocardial ContractionchemistryTolerabilityMineralocorticoidCardiologybiology.proteinDrug Therapy CombinationFemaleCanrenoic AcidCardiology and Cardiovascular MedicinebusinessFollow-Up Studiesmedicine.drugAmerican Heart Journal
researchProduct

P1013 : Chronic intermittent hypoxia is associated with liver damage and atherosclerosis in patients with non-alcoholic fatty liver disease

2015

all the steatosis grades, except S2 vs S3. The diagnostic performances of CAP in quantifying each steatosis grade was: for S ≥1 AUC=0.813 (cutoff 260dB/m, Se = 64.84%, Sp =87.27%, PPV=80.8%, NPV=75%, +LR =5.09, −LR =0.40, DA=76.11%); for S ≥2 AUC=0.822 (cutoff 285dB/m, Se = 69.70%, Sp =85.12%, PPV=47.9%, NPV=93.5%, +LR =4.68, −LR =0.36, DA=82.08%); for S ≥3 AUC=0.838 (cutoff 294dB/m, Se =83.33%, Sp =82.54%, PPV=23.3%, NPV=98.7%, +LR =4.77, −LR =0.20, DA=81.59%). AUCs calculated between two steatosis grades only were: 0.772 (for S0 vs S1), 0.874 (S0 vs S2), 0.904 (S0 vs S3), 0.659 (S1 vs S2), 0.777 (S1 vs S3), and 0.665 (S2 vs S3) respectively. Conclusions: Maximal diagnostic accuracy could …

medicine.medical_specialtyHepatologybusiness.industryFatty liverNon alcoholicDiseasemedicine.diseaseGastroenterologyInternal medicinemedicineCutoffChronic intermittent hypoxiaIn patientLiver damageSteatosisbusinessJournal of Hepatology
researchProduct

Beyond left ventricular ejection fraction there is a right heart that pumps.

2017

Heart Failuremedicine.medical_specialtyEjection fractionVentricular functionbusiness.industryHeartStroke VolumeStroke volume030204 cardiovascular system & hematologymedicine.diseaseVentricular Function Left03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineHeart failureInternal medicineRight heartCardiologyMedicineHumans030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessEuropean journal of heart failure
researchProduct

Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.

2009

Summary Background  In patients with cirrhosis, ascites is defined as refractory when it cannot be mobilized or recurs early in standard diuretic therapy. Aim  To compare the safety and efficacy of intravenous high-dose furosemide + hypertonic saline solutions (HSS) with repeated paracentesis in patients with cirrhosis and refractory ascites. Patients and methods  Eighty-four subjects (59/25 M/F) with cirrhosis, mostly of viral aetiology, admitted for refractory ascites, were randomly assigned to receive furosemide (250–1000 mg/bid i.v.) plus HSS (150 mL H2O with NaCl 1.4–4.6% or 239–187 mEq/L) (60 patients, Group A) or to repeated paracentesis and a standard diuretic schedule (24 patients,…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosismedicine.medical_treatmentPilot ProjectsRefractoryFurosemideAscitesmedicineParacentesishypertonic saline solutionHumansParacentesisPharmacology (medical)DiureticsAgedAged 80 and overSaline Solution HypertonicRCT; hypertonic saline solution; ascitesHepatologymedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryGastroenterologyFurosemideAscitesMiddle Agedmedicine.diseaseHypertonic salineSurgeryTreatment OutcomeEffusionAnesthesiaFemaleDiureticmedicine.symptombusinessRCTmedicine.drugAlimentary pharmacologytherapeutics
researchProduct

Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricul…

1994

This study was designed to evaluate total (t) and surface (s) β-adrenergic receptor (BAR) density and their relationship with central haemodynamics and left ventricular function in young subjects with central or peripheral obesity. A total of 31 obese subjects (BMI ≥30.5 kg. m−2 for males and >27.3 kg. m−2 for females) aged less than 40 years and without other risk factors for cardiovascular diseases (smoking, hypertension, diabetes and lipid abnormalities) were studied. Nine had peripheral obesity and 22 central obesity according to WHR values; there were 20 lean controls (BMI <25 kg. m−2 for males and <24.7 kg. m−2 for females). Casual (c) and 24 h ambulatory mean blood pressures (MBP-24 …

AdultMalemedicine.medical_specialtyCardiac outputSettore MED/09 - Medicina InternaMegalencephalic leukoencephalopathy with subcortical cystsEpinephrineDiastoleHemodynamicsBlood volumeVentricular Function LeftBody Mass IndexNorepinephrineRisk FactorsInternal medicineDiabetes mellitusReceptors Adrenergic betamedicineHumansInsulinLymphocytesObesitySystoleRadionuclide ImagingEjection fractionbusiness.industryHemodynamicsHeartmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiovascular DiseasesEchocardiographyBody ConstitutionRegression AnalysisPeripheral obesity Central Obesity Lymphocyte beta adrenergic receptors left ventricular functionFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.

2013

Background and Aim To evaluate if the presence of carotid atherosclerosis in patients with NAFLD, could be related to gene variants influencing hepatic fat accumulation and the severity of liver damage. Methods We recorded anthropometric, metabolic and histological data(Kleiner score) of 162 consecutive, biopsy-proven Sicilian NAFLD patients. Intima-media thickness(IMT), IMT thickening(IMT≥1 mm) and carotid plaques(focal thickening of >1.3 mm at the level of common carotid artery) were evaluated using ultrasonography. IL28B rs12979860 C>T, PNPLA3 rs738409 C>G, GCKR rs780094 C>T, LYPLAL1 rs12137855 C>T, and NCAN rs2228603 C>T single nucleotide polymorphisms were also assessed. The results we…

Carotid Artery DiseasesMalePathologylcsh:MedicineGastroenterology0302 clinical medicinePolymorphism (computer science)Non-alcoholic Fatty Liver DiseaseRisk FactorsGenotypeCommon carotid arterylcsh:ScienceATEROSCLEROSI0303 health sciencesMultidisciplinaryNONALCOHOLIC STEATOHEPATITISFatty liverMiddle Aged3. Good healthCarotid ArteriesCohortcardiovascular system030211 gastroenterology & hepatologyFemaleResearch ArticleAdultmedicine.medical_specialtyGenotypeSingle-nucleotide polymorphismPolymorphism Single Nucleotide03 medical and health sciencesmedicine.arteryDiabetes mellitusInternal medicinemedicineHumansClinical significancecardiovascular diseasesAllelesGenetic Association StudiesPNPLA3030304 developmental biologyAgedNAFLD PNPLA3 ATHEROSCLEROSISbusiness.industrylcsh:RMembrane ProteinsLipasemedicine.diseaseFatty Liverlcsh:Qbusiness
researchProduct

Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently…

2008

Studies have shown that patients with compensated heart failure (HF) receiving high diuretic doses associated with normal sodium diet and fluid intake restrictions demonstrated significant reductions in readmissions and mortality compared with those who received low-sodium diets, and over a 6-month observation period, a reduction in neurohormonal activation was also observed. The aim of this study was to evaluate the effects of different sodium diets associated with different diuretic doses and different levels of fluid intake on hospital readmissions and neurohormonal changes after 6-month follow-up in patients with compensated HF. Four hundred ten consecutive patients with compensated HF …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentchemistry.chemical_compoundElectrocardiographyInternal medicineHeart rateNatriuretic Peptide BrainReninmedicineHumansDiureticsAldosteroneAgedRetrospective StudiesHeart FailureAldosteroneEjection fractionmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryFurosemideSodium DietaryStroke VolumeDiet Sodium-Restrictedmedicine.diseaseBlood pressureTreatment OutcomechemistryEchocardiographyHeart failureCardiologyFemaleDiureticCardiology and Cardiovascular MedicinebusinessElectrocardiographymedicine.drugFollow-Up StudiesThe American journal of cardiology
researchProduct

Effects of captopril on plasma endothelin-1 during thrombolysis: Preliminary findings

1995

Pharmacologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentInfarctionCaptoprilGeneral MedicineThrombolysismedicine.diseaseEndothelin 1Text miningInternal medicinemedicineCardiologyPharmacology (medical)Cardiology and Cardiovascular Medicinebusinessmedicine.drugCardiovascular Drugs and Therapy
researchProduct

Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor bl…

2006

BACKGROUND.: In this study the effects of 24 weeks losartan and ramipril treatment, both alone and in combination, on blood pressure and left ventricular mass (LVM) and function, have been evaluated in hypertensives. METHODS.: 57 hypertensives with stage 1 and 2 essential hypertension were included. After 4 weeks run in, a randomized double-blind, 3 arm, double dummy, independent trial was used. All patients were randomly allocated to 3 treatment arms consisting of losartan (50 mg/daily), ramipril (5 mg/daily), and combined (losartan 50 mg/ramipril 5 mg/daily) for 24 weeks. LVM, LVM/h(2.7) and other echocardiographic measurements, BUN, creatinine and clearance and potassium were determined …

Ramiprillcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyLeft ventricular geometry and functionAngiotensin II receptor blockersLeft ventricular hypertrophyEssential hypertensionArticlechemistry.chemical_compoundInternal medicinemedicineAce-inhibitors Angiotensin II receptor blockers Left ventricular geometry and functioncardiovascular diseasesAce-inhibitorsCreatininebusiness.industrymedicine.diseaseAngiotensin IILosartanBlood pressurechemistrylcsh:RC666-701ACE inhibitorCardiologyCardiology and Cardiovascular Medicinebusinessmedicine.drugHeart International
researchProduct

Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease

2015

Background/Aims We assessed whether obstructive sleep apnea (OSA) and nocturnal hypoxemia are associated with severity of liver fibrosis and carotid atherosclerosis in patients with biopsy-proven NAFLD and low prevalence of morbid obesity. Secondary aim was to explore the association of OSA and hypoxemia with NASH and severity of liver pathological changes. Methods Consecutive patients (n = 126) with chronically elevated ALT and NAFLD underwent STOP-BANG questionnaire to estimate OSA risk and ultrasonographic carotid assessment. In patients accepting to perform cardiorespiratory polygraphy (PG, n = 50), OSA was defined as an apnea/hypopnea index ≥5. A carotid atherosclerotic plaque was defi…

AdultCarotid Artery DiseasesLiver CirrhosisMalemedicine.medical_specialtyBiopsylcsh:MedicinePolysomnographySeverity of Illness IndexGastroenterologyLiver Function TestsNon-alcoholic Fatty Liver DiseaseRisk FactorsSurveys and QuestionnairesInternal medicineSeverity of illnessPrevalencemedicineHumansHypoxialcsh:ScienceAgedNAFLD OSAS ATHEROSCLEROSISSleep Apnea ObstructiveMultidisciplinarymedicine.diagnostic_testbusiness.industrylcsh:RFatty liverApneaSleep apneaMiddle AgedAtherosclerosismedicine.diseasePlaque Atheroscleroticrespiratory tract diseases3. Good healthObstructive sleep apneaEndocrinologyFemalelcsh:Qmedicine.symptombusinessLiver function testsHypopneaResearch ArticlePLOS ONE
researchProduct

Carotid atherosclerosis in renal transplant recipients: Relationships with cardiovascular risk factors and plasma lipoproteins

1999

BACKGROUND: Renal transplant recipients have an increased incidence of cardiovascular disease, but less data exist about cerebrovascular atherosclerosis. In this study, we assessed the prevalence of carotid lesions as evaluated by B-mode ultrasonography in a group of renal transplant recipients, and we evaluated univariate and multivariate relationships between common risk factors and plasma lipoproteins and carotid lesions. METHODS: Fifty-seven renal transplant recipients and 113 age- and gender-matched controls underwent a complete clinical visit for the evaluation of risk factors present. In all subjects, a blood sample was collected for lipoprotein determination, and an ultrasound high-…

AdultMalemedicine.medical_specialtyBody Mass IndexPostoperative ComplicationsReference ValuesRisk FactorsInternal medicineDiabetes mellitusPrevalenceMedicineHumansCarotid StenosisRisk factorKidney transplantationTriglyceridesApolipoproteins BUltrasonographyTransplantationKidneymedicine.diagnostic_testApolipoprotein A-Ibusiness.industryVascular diseaseCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationmedicine.anatomical_structureCholesterolCardiologyFemalebusinessLipid profileKidney disease
researchProduct

OC.03.2 THE PRESENCE OF WHITE MATTER LESIONS IS ASSOCIATED WITH THE HISTOLOGICAL SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE

2016

medicine.medical_specialtyHepatologybusiness.industryInternal medicineFatty liverGastroenterologyMedicineNon alcoholicDiseasebusinessmedicine.diseaseGastroenterologyHyperintensityDigestive and Liver Disease
researchProduct

Relationship between transforming growth factor beta1 and progression of hypertensive renal disease.

2002

In this study the role of circulating transforming growth factor beta1 (TGFbeta1) on progression of renal hypertensive disease has been investigated. Fifty consecutive outpatients with essential hypertension were enrolled and divided into three groups, according to their urinary albumin excretion (UAE). Group A comprised 10 hypertensives with UAEor=20 mg/24 h (normoalbuminuric group); Group B included 21 hypertensives with UAE20300 mg/24 h (microalbuminuric group); Group C encompassed 19 hypertensives with UAEor= 300 mg/24 h (proteinuric group). In all patients UAE by immunonephelometric assay, circulating TGFbeta1 by a solid phase specific sandwich ELISA technique, BUN and creatinine by ro…

Malemedicine.medical_specialtyDiastoleLeft ventricular hypertrophyEssential hypertensionStatistics NonparametricMuscle hypertrophyExcretionTransforming Growth Factor beta1chemistry.chemical_compoundTransforming Growth Factor betaInternal medicineInternal MedicinemedicinePrevalenceAlbuminuriaHumansInterventricular septumCreatinineEjection fractionbusiness.industryMiddle Agedmedicine.diseasemedicine.anatomical_structureEndocrinologyHypertension RenovascularchemistryEchocardiographyCardiologyDisease ProgressionRegression AnalysisFemaleHypertrophy Left VentricularbusinessBiomarkersJournal of human hypertension
researchProduct

Exercise performance in hypertensives: felodipine vs cilazapril cross-over study

1999

medicine.medical_specialtyFelodipinebusiness.industryInternal medicineExercise performanceInternal MedicineCardiologyMedicineCilazaprilbusinessCrossover studymedicine.drugAmerican Journal of Hypertension
researchProduct

Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects

2003

Fifty-six young central obese patients were investigated to evaluate relationships between soluble E-selectin (sE-S), angiotensin-converting enzyme (ACE) gene polymorphism, left ventricular function and structure, and carotid morphology by determination of sE-S and ACE genotypes. Our results indicated that central obese subjects with concomitant higher levels of sE-S and ACE DD genotype may be characterized by early cardiovascular alterations and then considered a particular subset of subjects at higher risk of cardiovascular disease.

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina Internaangiotensin-converting-enzyme cardiovascular damageGenotypeArteriosclerosisEndocrinology Diabetes and MetabolismBlood PressureDiseasecentral obese subjectsPeptidyl-Dipeptidase ABody Mass Indexcirculating E-selectin genotype; angiotensin-converting-enzyme cardiovascular damage; central obese subjectsEndocrinologyRisk FactorsInternal medicineGenotypeE-selectinmedicineHumansInsulinObesityAllelesbiologyVentricular functionHemodynamicsHeartAngiotensin-converting enzymeGlucose Tolerance TestSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheIsoenzymesCarotid ArteriesEndocrinologyCardiovascular DiseasesEchocardiographyConcomitantbiology.proteinRegression AnalysisFemaleObese subjectsGene polymorphismE-Selectincirculating E-selectin genotypeMetabolism
researchProduct

The Usefulness of Bioelectrical Impedance Analysis in Differentiating Dyspnea Due to Decompensated Heart Failure

2007

Acute dyspnea poses a diagnostic challenge for physicians, and the current methods in differentiating cardiac from non-cardiac causes have been limited to date. Recently, the brain natriuretic peptide (BNP) rapid test has been validated in the emergency room. Nevertheless, the early accumulation of fluid in the interstitial space in the body and in the lungs, which characterizes patients with ADHF, is well estimated by BIA. We investigate whether bioelectrical impedance analysis (BIA) can serve as a noninvasive diagnostic tool in the differential diagnosis of acute decompensated heart failure (ADHF) in the emergency department (ED).A total of 292 patients presenting with acute dyspnea to th…

Malemedicine.medical_specialtyAcute decompensated heart failuremedicine.drug_classSensitivity and SpecificityDiagnosis DifferentialInternal medicineNatriuretic Peptide BrainElectric ImpedancemedicineNatriuretic peptideHospital dischargeHumansIntensive care medicineAgedHeart Failurebusiness.industryEmergency departmentMiddle Agedmedicine.diseaseBrain natriuretic peptideDyspneaROC CurveHeart failureCardiologyFemaleDifferential diagnosisCardiology and Cardiovascular MedicinebusinessBioelectrical impedance analysisAlgorithmsJournal of Cardiac Failure
researchProduct

Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings

2006

Background: There are several new strategies proposed to improve the outcome of patients with ST-elevation myocardial infarction (STEMI). One approach is the resurgent use of facilitated percutaneous coronary interventions (PCI). Until recently, deciding whether immediate PCI after combined treatment (facilitated PCI) is more appropriate than delayed PCI (short time) has not been investigated. The aim of this study, therefore, was to investigate the outcomes in patients initially successfully treated pharmacologically and immediate PCI < 2 hr, and in patients initially successfully treated with pharmacological therapy and with delayed PCI (12–72 h). Methods: 451 reperfused STEMI patients, a…

Malemedicine.medical_specialtyTiclopidineTime Factorsmedicine.medical_treatmentMyocardial InfarctionFacilitated Percutaneous Coronary InterventionPlatelet Glycoprotein GPIIb-IIIa ComplexGIIb/IIIa inhibitorDelayed Percutaneous Coronary InterventionsInternal medicineAngioplastymedicineAbciximabAcute myocardial InfarctionHumanscardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedbusiness.industryAnticoagulantsPercutaneous coronary interventionHematologyTirofibanMiddle AgedClopidogrelmedicine.diseaseCombined Modality TherapyClopidogrelsurgical procedures operativeTissue Plasminogen ActivatorConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinesstherapeuticsCombined therapyPlatelet Aggregation InhibitorsTIMIFollow-Up Studiesmedicine.drugJournal of Thrombosis and Thrombolysis
researchProduct

Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure

2010

Congestive heart failure (CHF) worsening is a worldwide cause of rehospitalization and mortality, specially during the early period after hospitalization. Fluid accumulation plays a key role in the pathophysiology of both acute heart decompensation and disease progression. The effective use of drugs to maintain restored clinical stabilization in recently discharged patients is a difficult task, and it relies on matching the most appropriately tailored therapy to specific clinical profiles. However, no successful treatment has been shown to reduce post-discharge readmission. We evaluated in a case-control study the effectiveness of an early and personalized congestion-guided ambulatory progr…

Malemedicine.medical_specialtyTime FactorsSettore MED/09 - Medicina InternaPost dischargeFluid intakeQuality of lifeAmbulatory careFurosemideAmbulatory CareInternal MedicinemedicineHumansDiureticsIntensive care medicineAgedHeart Failurebusiness.industryheart failure ambulatory follow-up furosemidecongestion post dischargeFurosemideMiddle Agedmedicine.diseasePatient DischargeTreatment OutcomeHeart failureAmbulatoryEmergency MedicineFluid TherapyFemalebusinessBioelectrical impedance analysisFollow-Up Studiesmedicine.drugInternal and Emergency Medicine
researchProduct

Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension

2007

Arterial hypertension is a significant cause of end-stage renal failure; effective treatment of hypertensive patients reduces the rate of progression of this disorder. ss-Blockers, particularly nonselective agents, are associated with deterioration of renal function in patients with chronic renal failure. Previous studies on the interaction of the beta1-selective adrenergic antagonist bisoprolol with kidney function have been performed only acutely and over the short term. This study was designed to evaluate the antihypertensive efficacy and effects on renal hemodynamics and function of bisoprolol during medium-term (6 mo) treatment of patients with mild to moderate essential hypertension. …

renal hemodynamicsAdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAdrenergic beta-AntagonistsHemodynamicsRenal functionBlood PressureKidney Function TestsPlaceboEssential hypertensionDrug Administration ScheduleRenal CirculationInternal medicineHeart ratemedicineAdrenergic antagonistBisoprololHumansPharmacology (medical)Antihypertensive Agentsbusiness.industryessential hypertensionGeneral MedicineMiddle Agedmedicine.diseaseBlood pressureBisoprololHypertensionCardiologyFemalebusinessmedicine.drugAdvances in Therapy
researchProduct

Wet BNP, fluid and hemodynamic status at discharge in Acute Heart Failure

2010

We comment the noteworthy results of Pimenta et al. concerning the significance of discharge BNP levels in acute HF patients. The innovation of Pimento's study is the systematic research of the potential relationship between BNP and clinical and hemodynamic parameters. We focused the attention on the importance of wet "BNP" in managing HF and its ability to reflect congestion and multiple underlying patho-physiological disturbances. The first observation, regarding the statistical order, underlines the importance of renal insufficiency at discharge in genesis of higher BNP levels. Secondly, we note that the relationship between natriuretic peptides and the non-invasive measurement of the fl…

Oncotic pressuremedicine.medical_specialtySettore MED/09 - Medicina InternaHeart diseasebusiness.industryHemodynamicsPlasma levelsmedicine.diseaseBrain natriuretic peptideSurgeryHeart failureInternal medicineAcute Heart failure Brain natriuretic peptideAmbulatoryCardiologyMedicineCardiology and Cardiovascular MedicinebusinessKidney diseaseInternational Journal of Cardiology
researchProduct

Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide.

1995

In this study the efficacy and safety of short-term cilazapril administration on renal haemodynamics were evaluated in mild to moderate hypertensive subjects. Our final goal was to evaluate whether the reduction in blood pressure achieved by treatment was associated with maintained renal function. After a run-in period with placebo, 40 hypertensive subjects without renal or cardiac diseases were randomly allocated to a double-blind 4 week controlled trial with cilazapril 5 mg once a day (20 patients) or hydrochlorothiazide 25 mg once a day (20 patients). Renal haemodynamics measurements included effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) by radionuclide study us…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaUrologyRenal functionAngiotensin-Converting Enzyme InhibitorsCilazaprilEssential hypertensionRenal CirculationHydrochlorothiazideDouble-Blind MethodInternal medicineInternal MedicinemedicineAngiotensin-Converting Enzyme InhibitorsAntihypertensive Agents Hydrochlorothiazide CilazaprilHumansAntihypertensive AgentsAgedRenal circulationbusiness.industryHemodynamicsGeneral MedicineEffective renal plasma flowCilazaprilMiddle Agedmedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareFiltration fractionmedicine.anatomical_structureEndocrinologyHydrochlorothiazideTreatment OutcomeRenal blood flowHypertensionSettore BIO/14 - FarmacologiaFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugGlomerular Filtration RateBlood pressure
researchProduct

Intavenous high dose furosemide plus small volume of hypertonic saline solutions (HSS) versus seriated paracentesis in treatment of refractory ascite…

2008

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrySmall volumeFurosemideHypertonic salineSurgeryAnesthesiaInternal MedicineParacentesismedicineRefractory ascitesbusinessmedicine.drug
researchProduct

Long-Term Effects of Dietary Sodium Intake on Cytokines and Neurohormonal Activation in Patients With Recently Compensated Congestive Heart Failure

2009

Abstract Background A growing body of evidence suggests that the fluid accumulation plays a key role in the pathophysiology of heart failure (HF) and that the inflammatory and neurohormonal activation contribute strongly to the progression of this disorder. Methods and Results The study evaluated the long-term effects of 2 different sodium diets on cytokines neurohormones, body hydration and clinical outcome in compensated HF outpatients (New York Heart Association Class II). A total of 173 patients (105 males, mean age 72.5±7) recently hospitalized for worsening advanced HF and discharged in normal hydration and in clinical compensation were randomized in 2 groups (double blind). In Group …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPlasma renin activityGastroenterologychemistry.chemical_compoundDouble-Blind MethodInternal medicinemedicineHumansAgedAged 80 and overHeart FailureNeurotransmitter AgentsAldosteronebusiness.industryFurosemideSodium Dietarymedicine.diseaseBrain natriuretic peptidePathophysiologyAldosterone BNP bioelectrical impedance congestive heart failure cytochines plasma renin activatityEndocrinologyCytokinechemistryHeart failureCytokinesFemaleDiureticCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugFollow-Up Studies
researchProduct

Chronic Intermittent Hypoxia is associated with Liver Damage and Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease

2015

medicine.medical_specialtyHepatologybusiness.industryFatty liverGastroenterologyNon alcoholicDiseasemedicine.diseaseGastroenterologyInternal medicinemedicineChronic intermittent hypoxiaIn patientLiver damagebusinessDigestive and Liver Disease
researchProduct

Captopril does not affect plasma endothelin-1 during thrombolysis and reperfusion.

1995

Studies showed that endothelin-1 (ET-1) was increased in the acute myocardial infarction (AMI). Experimental studies reported that captopril was able to reduce ET-1 secretion, and that ET-1 was increased during reperfusion. This study was aimed to verify if captopril was able to reduce plasma ET-1 during thrombolysis in AMI. Seventy-three patients, hospitalized for suspected AMI within 4 h from the onset of symptoms suitable for thrombolysis (1st episode), Killip class 1-2, were randomized (double blind) into two groups: group 1 (37 pts), 8 F/29 M, received captopril, 6.25 mg, orally 15 min before thrombolysis. Group 2: (36 pts) 8 F/28 M, received placebo before thrombolysis. All patients m…

Malemedicine.medical_specialtyCaptoprilTime Factorsmedicine.medical_treatmentMyocardial InfarctionAdministration OralAngiotensin-Converting Enzyme InhibitorsBlood PressureMyocardial ReperfusionPlaceboAnginaPlacebosElectrocardiographyDouble-Blind MethodHeart RateInternal medicineFibrinolysismedicineHumansThrombolytic TherapyMyocardial infarctionAngina UnstableCreatine KinaseKillip classbusiness.industryUnstable anginaEndothelinsCaptoprilThrombolysismedicine.diseaseRecombinant ProteinsSurgeryIsoenzymesTissue Plasminogen ActivatorCardiologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational journal of cardiology
researchProduct

Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

2011

BACKGROUND AND AIMS: There are contrasting results in studies of cardiovascular risk in patients with genotype 1 chronic hepatitis C (G1 CHC). We evaluated the prevalence of carotid atherosclerosis compared with a control population in order to assess the potential association between atherosclerosis, host and viral factors, and liver histological features. MATERIALS AND METHODS: One hundred seventy-four consecutive biopsy-proven G1 CHC patients were evaluated by anthropometric and metabolic measurements. One hundred seventy-four patients attending an outpatient cardiology unit were used as controls. Intima-media thickness (IMT) and carotid plaques, defined as focal thickening of > 1.3 mm a…

Carotid Artery DiseasesMaleLIVER BIOPSYComorbiditySeverity of Illness IndexGastroenterologyBody Mass IndexReference ValuesOdds RatioPrevalenceProspective StudiesProspective cohort studySettore MED/12 - Gastroenterologiamedicine.diagnostic_testBiopsy NeedleSmokingHepatitis CMiddle AgedPrognosisHCV ATHEROSCLEROSI FIBROSISImmunohistochemistryItalyCAROTID ATHEROSCLEROSISFemaleRadiologyAdultmedicine.medical_specialtySettore MED/08 - Anatomia PatologicaCHRONIC HEPATITIS CRisk AssessmentYoung AdultAge DistributionInternal medicineDiabetes mellitusBiopsyHEPATIC FIBROSISConfidence IntervalsmedicineHumansObesitySex DistributionAgedAnalysis of VarianceHepatologybusiness.industryCase-control studyUltrasonography DopplerOdds ratioHepatitis C ChronicHepatologymedicine.diseaseDiabetes Mellitus Type 2Case-Control StudiesMultivariate AnalysisLinear ModelsSteatosisbusinessHepatology
researchProduct

803 Effects of high dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus, in re…

2003

Bolus (medicine)Hypertonic Saline SolutionSmall volumebusiness.industryAnesthesiaHeart failuremedicineFurosemideCardiology and Cardiovascular Medicinemedicine.diseasebusinessmedicine.drugEuropean Journal of Heart Failure Supplements
researchProduct

The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?

2012

Glucocorticoid administration is not recommended in patients with heart failure because of its related sodium and fluid retention. However, previous experimental and clinical studies have demonstrated that glucocorticoids can also induce a diuretic effect and improve renal function in patients with acute decompensated heart failure (ADHF) with refractory diuretic resistance. We report the case of a 65-year-old man with a known diagnosis of aortic stenosis, systolic ventricular dysfunction, and chronic obstructive pulmonary disease who was admitted for ADHF. After 3 days, during which resistance to conventional therapy was observed, intravenous methylprednisolone (60 mg/d) was added to ongoi…

Malemedicine.medical_specialtyAcute decompensated heart failuremedicine.medical_treatmentRenal functionMethylprednisoloneRefractoryInternal medicinemedicineHumansDiureticsGlucocorticoidsAgedHeart Failurebusiness.industryGeneral Medicinemedicine.diseaseBrain natriuretic peptideStenosisglucocorticoid. acute decompensated hert failureEndocrinologyHeart failureAcute DiseaseEmergency MedicineCardiologyDiureticbusinessGlucocorticoidmedicine.drug
researchProduct

Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo.

1993

In this study the efficacy and safety of short-term amlodipine administration on renal haemodynamics were evaluated in mild to moderate hypertensive subjects. Our final goal was to evaluate whether the reduced blood pressure induced by treatment was associated with maintenance of renal function. After a run-in period with placebo, 30 hypertensive patients without cardiac or renal diseases were randomly allocated to a double-blind 4 weeks controlled study with amlodipine 10 mg once a day (15 patients) or placebo (15 patients). Renal haemodynamic measurements included effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) by radionuclide study using 131I-hippuran and 99mTc, w…

AdultMalemedicine.medical_specialtyRenal Blood Flow Effectivemedicine.medical_treatmentRenal functionPlacebolaw.inventionRandomized controlled trialDouble-Blind MethodlawReninmedicineHumansPharmacology (medical)AmlodipinePharmacologyChemotherapybusiness.industryGeneral MedicineMiddle AgedSurgeryClinical trialUrodynamicsBlood pressureAnesthesiaRenal blood flowHypertensionFemaleVascular ResistanceAmlodipinebusinessmedicine.drugGlomerular Filtration RateEuropean journal of clinical pharmacology
researchProduct

Hemodynamic Changes in Patients with Essential Hypertension after Therapy with Muzolimine

1987

Muzolimine is a new nonsulfonamide diuretic belonging to the pyrazolinone group (1).It is a potent high-ceiling diuretic agent like furosemide and bumetanide with long duration of action like thiazides (1, 2).

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCardiac indexFurosemideHemodynamicsEssential hypertensionmedicine.diseasechemistry.chemical_compoundchemistryInternal medicinemedicineCardiologyMuzolimineIn patientDiureticbusinessBumetanidemedicine.drug
researchProduct

The pathophysiology of acute heart failure: the key role of fluid accumulation

2008

business.industryHeart failureKey (cryptography)MedicineFluid accumulationCardiology and Cardiovascular MedicinebusinessBioinformaticsmedicine.diseasePathophysiology
researchProduct

Time to ferry heart failure onto new shores: The need to effectively customize long-term therapy

2011

heart failure therapymedicine.medical_specialtybusiness.industryTreatment outcomeDisease progressionMEDLINEmedicine.diseaseHeart failureInternal medicinemedicineCardiologyLong term therapyCardiology and Cardiovascular MedicineIntensive care medicinebusinessAmerican Heart Journal
researchProduct

158: Is Bioelectrical Impedance Analysis Helpful for Heart Failure Management in the Emergency Department?

2008

business.industryHeart failureEmergency MedicinemedicineEmergency departmentMedical emergencymedicine.diseasebusinessBioelectrical impedance analysisAnnals of Emergency Medicine
researchProduct

Carotid atherosclerosis in hypercholesterolemic patients: Relationship with cardiovascular events

2001

Background and Aim: Extracranial cerebrovascular atherosclerosis is a common feature of hypercholesterolemia and carotid lesions are good predictors of cardiovascular events in the general population. Factors associated with the carotid damage of hypercholesterolemic patients and their relationships with the occurrence of clinical events are investigated in this study. Methods and Results: One hundred and seventeen cardiovascular event-free hypercholesterolemic subjects underwent a complete clinical examination to look for additional risk factors. A blood sample was collected for lipoprotein determination and an ultrasound high resolution B-mode imaging examination of the common carotid art…

Carotid Artery DiseasesMaleNutrition and DieteticsSettore MED/09 - Medicina InternaCarotid Artery CommonEndocrinology Diabetes and MetabolismHypercholesterolemiaAge FactorsMedicine (miscellaneous)Middle AgedCardiovascular diseaseCholesterolRisk FactorsAtherosclerosiHypertensionUltrasoundPrevalenceHumansFemaleCardiology and Cardiovascular MedicineTriglyceridesFollow-Up StudiesUltrasonographyFood Science
researchProduct

Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction.

2019

Left ventricular ejection fraction (EF) is helpful to differentiate heart failure (HF) phenotype in clinical practice. The aim of the study was to identify simple echocardiographic predictors of post-discharge all-cause mortality in hospitalized HF patients. Patients with acute HF (75 ± 9.8 years), classified in preserved (≥ 50%) and reduced (&lt; 50%) EF (HFpEF and HFrEF, respectively), were enrolled. The mean follow-up period was of 25.4 months. Patients definitively analyzed were 135. At multivariate Cox model, right ventricular diameter (RVd), inferior vena cava diameter (IVCd) and blood urea nitrogen (BUN) resulted to be significantly associated with all-cause mortality in HFpEF (HR 2.…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart Ventricles030204 cardiovascular system & hematologyInferior vena cava03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineBlood urea nitrogenAgedAged 80 and overHeart FailureCOPDEjection fractionbusiness.industryProportional hazards modelheart failure echocardiography mortalityStroke VolumeMiddle AgedWeights and Measuresmedicine.diseasePrognosismedicine.veinItalyEchocardiographyHeart failureEmergency MedicineCardiologyFemalebusinessHeart failure with preserved ejection fractionAll cause mortalityInternal and emergency medicine
researchProduct

Does plasma endothelin during thrombolysis depend on infarct size? A pilot study

1995

Dear Sir, Endothelin is a recently discovered endotheliumderived vasoconstrictive peptide [1]. Endothelin's actions are altered in various models of cardiac injury [2]. Furthermore, it has been shown that endothelin is increased during reperfusion [2]. Studies have shown a significant increase in endothelin-1 (ET-1) in the early phases of acute myocardial infarction (AMI) and percutaneous transluminal coronary angioplasty (PTCA) [3-8]. In addition, a significant inverse relation between ventricular function and plasma ET-1 has been shown [6]. These data suggest that ET-1 may provide a marker of endothelial injury in the early phases of coronary ischemia or may even contribute to alterations…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionInfarctionPilot ProjectsInternal medicinemedicineHumansThrombolytic TherapyPharmacology (medical)cardiovascular diseasesMyocardial infarctionAgedPharmacologybusiness.industryEndothelinsGeneral MedicineCoronary ischemiaThrombolysisPlasma levelsMiddle Agedmedicine.diseaseInfarct sizeEndothelin 1Tissue Plasminogen Activatorcardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessEndothelin receptorCardiovascular Drugs and Therapy
researchProduct

Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary al…

2004

OBJECTIVE: In this study, the relationship between circulating transforming growth factor beta1 (TGFbeta1) and urinary albumin excretion (UAE) has been investigated in non-obese and central obese hypertensive patients. DESIGN AND PATIENTS: Fifty-eight consecutive hypertensive outpatients both lean and with central obesity were enrolled and divided in three groups, according to their body mass index (BMI) values. Group A: 16 lean hypertensives (men with BMI or = 25 kg/m2 and 24.7 kg/m2 and or = 30 kg/m2 and women with BMI > or = 27.3 kg/m2). MEASURES: In all patients, UAE, by immunonephelometric assay, circulating TGFbeta1 by a solid-phase specific sandwich enzyme-linked immunosorbent assay …

AdultMalemedicine.medical_specialtyHypertension RenalSettore MED/09 - Medicina Internacentral obesity hypertension transforming growth factor beta1 urinary albumin excretionOverweightBody Mass IndexExcretionTransforming Growth Factor beta1chemistry.chemical_compoundElectrocardiographyTransforming Growth Factor betaInternal medicineInternal MedicineMedicineAlbuminuriaHumansObesityBlood urea nitrogenAgedSettore MED/14 - NefrologiaCreatininebusiness.industryBody Weightnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseObesitySettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheEndocrinologychemistryHeart Function TestsAlbuminuriaRegression AnalysisFemaleKidney Diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexKidney disease
researchProduct

Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects

2004

Despite the fact that it is known that hypertension may be associated to early atherosclerosis manifestations, few data are to date available on the relationship between early carotid abnormalities and left ventricular diastolic dysfunction. To address this issue, 142 hypertensive patients (64 females and 78 males) younger than 55 years, at the first diagnosis of mild-to-moderate essential hypertension (WHO/ISH criteria), were selected from a database consisting of 3541 subjects referred to ultrasound cardiovascular laboratory in the last 5 years. Carotid intima-media thickness (IMT) was detected by high-resolution vascular ultrasound and left ventricular structure and function by the use o…

AdultCarotid Artery DiseasesMalemedicine.medical_specialtyTime FactorsSettore MED/09 - Medicina Internaatherosclerosis carotid arteries diastoleDiastoleDoppler echocardiographyEssential hypertensionLeft ventricular hypertrophyVentricular Dysfunction LeftDiastoleInternal medicineInternal MedicineHumansMedicinecardiovascular diseasesUltrasonographymedicine.diagnostic_testbusiness.industryVascular diseaseMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structureHypertensionCirculatory systemcardiovascular systemCardiologyFemalebusinessIsovolumic relaxation timeArtery
researchProduct

Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs.

1997

Thirty adult patients with distal, monolateral deep vein thrombosis of the lower limbs were randomly treated for sixty days either with subcutaneous Ca-Heparin or with Sulodexide, administered IM for ten days and orally for fifty days. The thrombus accretion above the knee, the venous pressures of the affected leg, the clinical sympto matology, and some laboratory coagulative tests were monitored throughout the admin istration period. Local tolerability of the two treatments was also evaluated.The two applied treatments evidenced a net antithrombotic activity, preventing thrombus accretion above the knee, improving with the same efficacy the venous pressures in the affected legs, and simila…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.drug_classDeep vein030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsHumansMedicine030212 general & internal medicineThrombusAgedGlycosaminoglycansmedicine.diagnostic_testHeparinbusiness.industryAnticoagulantHeparinMiddle AgedThrombophlebitismedicine.diseaseThrombosisSulodexideSurgerymedicine.anatomical_structureTolerabilityAnesthesiaSettore BIO/14 - FarmacologiaFemaleAdult Aged Female Fibrinolytic Agents/administration & dosage Fibrinolytic Agents/therapeutic use* Glycosaminoglycans/administration & dosage Glycosaminoglycans/therapeutic use* Heparin/therapeutic use* Humans Male Middle Aged Thrombophlebitis/drug therapy*Cardiology and Cardiovascular Medicinebusinessmedicine.drugPartial thromboplastin time
researchProduct

Clinical and haemodynamic effects of ketanserin in lean and obese hypertensive patients.

1990

Systemic and central haemodynamics were evaluated in 10 lean and 10 obese hypertensive patients (World Health Organization stage I – II) after treatment for 8 weeks with a serotoninergic antagonist, such as ketanserin. Blood pressure and heart rate were recorded and first-pass radionuclide angiocardiography was performed to determine cardiac output, cardiac index and ejection fraction of the left ventricle; total peripheral resistance was also calculated. In both obese and lean patients, ketanserin significantly reduced diastolic ( P &lt; 0.05) and mean ( P &lt; 0.005) blood pressure but no significant changes in systolic blood pressure, cardiac output, cardiac index and ejection fraction …

AdultMalemedicine.medical_specialtyCardiac outputKetanserinDiastoleCardiac indexHemodynamicsBlood PressureBiochemistryInternal medicineHeart ratemedicineHumansObesityCardiac OutputEjection fractionbusiness.industryBiochemistry (medical)HemodynamicsCell BiologyGeneral MedicineMiddle AgedLipidsEndocrinologyBlood pressureHypertensionCardiologyFemaleVascular ResistanceKetanserinbusinessmedicine.drugThe Journal of international medical research
researchProduct

Bed-side inferior vena cava diameter and mean arterial pressure predict long-term mortality in hospitalized patients with heart failure: 36 months of…

2015

In discharged patients with heart failure (HF), diverse conditions can intervene to worsen outcome. We would investigate whether such factors present on hospital admission can affect long-term mortality in subjects hospitalized for acute HF.One hundred twenty-three consecutive patients hospitalized for acute HF (mean age 74.8 years; 57% female) were recruited and followed for 36 months after hospitalization.At multivariate Cox model, only inferior vena cava (IVC) diameter and mean arterial pressure (MAP) registered bed-side on admission, resulted, after correction for all confounders factors, the sole factors significantly associated with a higher risk of all-cause mortality in long-term (H…

MaleSettore MED/09 - Medicina InternaLongitudinal Studie030204 cardiovascular system & hematologyCohort Studies0302 clinical medicine030212 general & internal medicineLongitudinal StudiesProspective StudiesMultivariate AnalysiAged 80 and overEjection fractionOrgan SizeMiddle AgedPrognosisMean arterial pressureHospitalizationmedicine.veinPoint-of-Care Testingcardiovascular systemCardiologyPopulation studyFemaleHumanmedicine.medical_specialtyMean arterial pressurePrognosiRenal functionVena Cava InferiorInferior vena cava03 medical and health sciencesInternal medicineInferior vena cava diameterInternal MedicinemedicineHumansArterial PressureMortalityAgedProportional Hazards ModelsHeart FailureProportional hazards modelbusiness.industrymedicine.diseaseProspective StudieBlood pressureHeart failureMultivariate AnalysisProportional Hazards ModelCohort StudiebusinessEuropean journal of internal medicine
researchProduct

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease

2016

Abstract We tested whether nonalcoholic fatty liver disease (NAFLD) and/or its histological severity are associated with vascular white matter lesions (WML) in patients with biopsy-proven NAFLD and in non-NAFLD controls. Data were recorded in 79 consecutive biopsy-proven NAFLD, and in 82 controls with normal ALT and no history of chronic liver diseases, without ultrasonographic evidence of steatosis and liver stiffness value  45 years (OR 3.09, 95% CI: 1.06–9.06, P = 0.03; and OR 11.1, 95% CI: 1.14–108.7, P = 0.03), and F2–F4 fibrosis (OR 3.36, 95% CI: 1.29–8.73, P = 0.01; and OR 5.34, 95% CI: 1.40–20.3, P = 0.01) were independently associated with WML (mostly of mild grade) by multivariate…

Liver CirrhosisMalePathologyBiopsySeverity of Illness IndexGastroenterology0302 clinical medicineRisk FactorsNon-alcoholic Fatty Liver DiseaseFibrosisNonalcoholic fatty liver diseaseUltrasonography4500Brain DiseasesSettore MED/12 - Gastroenterologiamedicine.diagnostic_testMedicine (all)Brain DiseaseGeneral MedicineMiddle AgedMagnetic Resonance ImagingWhite MatterFrontal Lobemedicine.anatomical_structureLiverFemale030211 gastroenterology & hepatologyNAFLD liver biopsy fibrosis white matter lesionsResearch ArticleHumanmedicine.medical_specialtyLiver CirrhosiObservational StudySettore MED/08 - Anatomia PatologicaDiagnosis DifferentialWhite matter03 medical and health sciencesInternal medicineBiopsySeverity of illnessmedicineHumansbusiness.industryRisk Factornutritional and metabolic diseasesmedicine.diseasedigestive system diseasesHyperintensityDifferential diagnosisSteatosisSettore MED/36 - Diagnostica Per Immagini E Radioterapiabusiness030217 neurology & neurosurgeryMedicine
researchProduct

Hiatal herniation of the stomach and pancreas in a patient with oxygen desaturations

2013

Hiatal hernia (HH), a neglected cause of cardiorespiratory symptoms, is a frequent entity characterized by the displacement of the gastro- esophageal junction and part of the stomach into the mediastinum. Although often asymptomatic, HH may also exert a wide spectrum of clinical presentations due to cardio-pulmonary compression, including acute cardiovascular events such as arrhythmias, post-prandial syncope, angina-like chest pain, recurrent acute heart failure, hemodynamic collapse, electrocardiographic changes (T-wave inversion, ST elevation) simulating myocardial ischemia or pericarditis, and respiratory manifestations that can range from exercise intolerance and dyspnea on exertion to …

medicine.medical_specialtybusiness.industryST elevationGeneral MedicineExercise intolerancemedicine.diseaseChest painAsymptomaticPulmonary function testingHiatal hernia ;respiratory desaturation ; pancreas; pulmonary hypertensionHiatal herniaPericarditisHeart failureInternal medicineCardiologyMedicineMedicinecardiovascular diseasesmedicine.symptombusinessLetter to the EditorThe Libyan Journal of Medicine
researchProduct

Central obesity and hypertensionThe role of plasma endothelin

1996

Hypertension and central obesity are two conditions closely linked, but the mechanisms responsible for obesity-associated hypertension are still unclear. In the last few years, several studies addressed the role of endothelin-1 (ET-1) in the development and maintenance of hypertension. This study was designed to evaluate plasma ET-1 in normotensive and hypertensive central obese subjects compared with a lean healthy group. Our final goal was to analyze the relationship between plasma ET-1, blood pressure, and left ventricular structure and function in central obese subjects (both normotensives and hypertensives). ET-levels have been assessed by the radioimmunoassay method in 20 lean normote…

AdultMalemedicine.hormoneMean arterial pressuremedicine.medical_specialtyAmbulatory blood pressureMegalencephalic leukoencephalopathy with subcortical cystsRadioimmunoassayBody Mass IndexEndothelinsVentricular Dysfunction LeftHeart RateInternal medicineInternal MedicinemedicineHumansRadionuclide AngiographyEndothelin-1business.industryStroke VolumeStroke volumeBlood Pressure Monitoring Ambulatorymedicine.diseaseBody HeightObesity MorbidMean blood pressureBlood pressureEndocrinologyEchocardiographyHypertensionBody ConstitutionRegression AnalysisFemalebusinessBody mass indexAmerican Journal of Hypertension
researchProduct

Relationship between left ventricular hypertrophy, diastolic function and extracardiac atherosclerosis in newly diagnosed hypertensives

2001

Body surface areamedicine.medical_specialtyMegalencephalic leukoencephalopathy with subcortical cystsbusiness.industryDiastoleNewly diagnosedmedicine.diseaseLeft ventricular hypertrophyIntima-media thicknessmedicine.arteryInternal medicineInternal MedicineCardiologyMedicineDiastolic functionRadiologyCommon carotid arterybusinessAmerican Journal of Hypertension
researchProduct

Evaluation of regional haemodynamics and alterations of vascular wall of the lower limbs in hypertensive subjects

1995

This study was designed to analyse the relationship between arterial hypertension and changes in arterial blood flow and vascular wall damage of the lower limbs in hypertensive patients with various degrees of hypertension. Six hundred and fifty-four hypertensive patients (421 males and 233 females) aged 35 to 70 years and 88 healthy subjects (63 males and 25 females) aged 39 to 60 years were studied. Strain-gauge plethysmography of the lower limbs was used to calculate arterial calf blood flow (RF), arterial calf blood flow after post-ischaemic hyperaemia (PF), basal and minimal vascular resistances (BVR and MVR), time to reach peak flow (tPF), time until 50% reduction of peak flow (tT1/2)…

AdultMaleDuplex ultrasonographymedicine.medical_specialtySettore MED/09 - Medicina InternaHemodynamicsEssential Hypertension Arterial blood flow of the lower limbs medial-intima thickeningHyperaemiaInternal medicinemedicine.arterymedicinePlethysmographHumansKneeAgedUltrasonographyLegbusiness.industryHemodynamicsBlood flowArteriesMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolarePopliteal arterySurgeryMean blood pressuremedicine.anatomical_structureRegional Blood FlowHypertensionCardiologyFemaleVascular Resistancemedicine.symptomCardiology and Cardiovascular MedicinebusinessTunica IntimaTunica MediaArtery
researchProduct

Effects of Middle-Term Treatment with Nifedipine on Hemodynamic Parameters and on Left Ventricular Function in Hypertensive Patients

1988

medicine.medical_specialtyHistory and Philosophy of ScienceVentricular functionNifedipinebusiness.industryGeneral NeuroscienceInternal medicinemedicineCardiologyHemodynamicsbusinessGeneral Biochemistry Genetics and Molecular Biologymedicine.drugAnnals of the New York Academy of Sciences
researchProduct

Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated …

2011

BACKGROUND: The aim of the study was to verify the effects of hypertonic saline solution (HSS) plus a high furosemide dose and light restriction of sodium intake compared with a high-dose infusion of furosemide alone on pulmonary capillary wedge pressure (PCWP), as determined by Doppler echocardiography and tissue Doppler imaging in patients suffering from decompensated heart failure. METHODS AND RESULTS: Consecutive patients in New York Heart Association functional class IV, unresponsive to oral high doses of furosemide up to 250-500 mg/d and/or combinations of diuretics, with ejection fraction <40%, serum creatinine <2 mg/dL, blood urea nitrogen ≤60 mg/dL, reduced urinary volume (<500 mL/…

MaleSettore MED/09 - Medicina Internamedicine.medical_treatmentHemodynamicsDoppler echocardiographyDouble-Blind MethodFurosemidemedicinePlethysmographHumansPlethysmography ImpedancePulmonary Wedge PressurePulmonary wedge pressureDiureticsAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionmedicine.diagnostic_testDiuretics Saline Solution Hypertonic Furosemide PCWPbusiness.industryFurosemidemedicine.diseaseEchocardiographyHeart failureAnesthesiaFemaleDiureticCardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct

Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.

2015

Introduction Diuretic responsiveness in patients with chronic heart failure (CHF) is better assessed by urine production per unit diuretic dose than by the absolute urine output or diuretic dose. Diuretic resistance arises over time when the plateau rate of sodium and water excretion is reached prior to optimal fluid elimination and may be overcome when hypertonic saline solution (HSS) is added to high doses of furosemide. Methods Forty-two consecutively hospitalized patients with refractory CHF were randomized in a 1:1:1 ratio to furosemide doses (125 mg, 250 mg, 500 mg) so that all patients received intravenous furosemide diluted in 150 ml of normal saline (0.9%) in the first step (0–24 h…

MaleDose–response curves; Furosemide; Heart failure; Hypertonic saline; Refractory chronic heart failure; Pharmacology (medical); Medicine (all)medicine.medical_treatmentSodiumchemistry.chemical_elementHypertonic salineRefractoryDrug toleranceFurosemidemedicineRefractory chronic heart failureHumansPharmacology (medical)DiureticsAgedOriginal ResearchMedicine(all)Aged 80 and overHeart FailureSaline Solution HypertonicDose-Response Relationship Drugbusiness.industryMedicine (all)Osmolar ConcentrationSodiumFurosemideGeneral MedicineDrug ToleranceMiddle Agedmedicine.diseaseHypertonic salineDose–response relationshipchemistryHeart failureAnesthesiaChronic DiseaseDrug Therapy CombinationFemaleDiureticDose–response curvebusinessDose–response curvesmedicine.drugAdvances in therapy
researchProduct

Nutritional predictors of mortality after discharge in elderly patients on a medical ward

2015

Background: Malnutrition in elderly inpatients hospitalized on medical wards is a significant public health concern. The aim of this study was to investigate nutritional markers as mortality predictors following discharge in hospitalized medical elderly patients. Materials and methods: This is a prospective observational cohort study with follow-up of 48 months. Two hundred and twenty-five individuals aged 60 and older admitted from the hospital emergency room in the past 48 h were investigated at the medical ward in the University hospital in Palermo (Italy). Anthropometric and clinical measurements, Mini-nutritional Assessment (MNA) questionnaire, bioelectrical (BIA) phase angle (PA), gri…

Male0301 basic medicinePediatricsmini-nutritional assessmentClinical BiochemistryCoronary DiseaseComorbidityBiochemistryCohort StudiesGrip strength0302 clinical medicineRisk FactorsElectric ImpedanceMedicineProspective Studies030212 general & internal medicineProspective cohort studyAged 80 and overAnthropometryHand StrengthBioimpedanceMedicine (all)Hazard ratioAge FactorsGeneral MedicineMiddle AgedPrognosisPatient Dischargephase angleItalyHypertensionFemalehospitalizationCohort studymedicine.medical_specialtyNutritional Statusmalnutrition03 medical and health sciencesPatients' RoomsHumansAgedProportional Hazards Models030109 nutrition & dieteticsbusiness.industryProportional hazards modelAnthropometrymedicine.diseasemortalityComorbidityConfidence intervalNutrition AssessmentDiabetes Mellitus Type 2Kidney Failure ChronicbusinessFollow-Up StudiesEuropean Journal of Clinical Investigation
researchProduct

The challenge of the volume status assessment in heart failure.

2009

medicine.medical_specialtySystoleBlood volumeDoppler echocardiographyVentricular Dysfunction LeftInternal medicinemedicineIntravascular volume statusVentricular PressureHumansSystoleHeart FailureBlood Volumemedicine.diagnostic_testbusiness.industryDisease progressionmedicine.diseasePrognosisEchocardiography DopplerHeart failureCardiologyVentricular pressureheart failure volume status assessmentDisease ProgressionCardiology and Cardiovascular MedicinebusinessAmerican heart journal
researchProduct

Effect of dual blockade of renin–angiotensin system on TGFβ1 and left ventricular structure and function in hypertensive patients

2007

The effects of 24 weeks losartan and ramipril treatment, both alone and in combination, on left ventricular mass (LVM), circulating transforming growth factor beta1 (TGFbeta1), procollagen type I (PIP) and III (PIIIP), have been evaluated in hypertensive (HT) patients. A total of 57 HT with stage 1 and 2 essential hypertension were included. After 4 weeks run in, a randomized double-blind, three arms, double dummy, independent trial was used. All HT patients were randomly allocated to three treatment arms consisting of losartan (50 mg/daily), ramipril (5 mg/ daily) and combined (losartan 50 mg/daily + ramipril 5 mg/daily) for 24 weeks. TGFbeta1, PIP and PIIIP, LVM, LVM/h(2.7) and other echo…

AdultMalemedicine.medical_specialtyLeft ventricular structureHeart VentriclesBlood PressureEnzyme-Linked Immunosorbent AssayAngiotensin II Receptor BlockersPeptide hormoneSeverity of Illness IndexDual blockadeCollagen Type ILosartanVentricular Function LeftRenin-Angiotensin SystemTransforming Growth Factor beta1Double-Blind MethodRamiprilInternal medicineRenin–angiotensin systemPrevalenceInternal MedicineHumansMedicineAntihypertensive AgentsUltrasonographyAnalysis of Variancebusiness.industryMiddle AgedAngiotensin IICollagen Type IIITreatment OutcomeEndocrinologyItalyHypertensionACE inhibitorDrug Therapy CombinationFemaleHypertrophy Left VentricularbusinessBiomarkersmedicine.drugJournal of Human Hypertension
researchProduct

Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with hep…

2010

Abstract Introduction The aim of this study was to assess the effect of thrombolysis versus heparin treatment on echocardiographic parameters and clinical outcome, during hospitalization and within the first 180 days after admission, in patients with first episode of submassive pulmonary embolism (SPE) and right ventricle dysfunction (RVD). Methods Consecutive patients (age, 18–75 years) with a first episode of SPE, symptoms onset since no more than 6 hours, normal blood pressure (> 100 mm Hg), echocardiographic evidence of RVD and positive lung spiral computed tomography were double-blind randomized: 1 group received 100 mg of alteplase (10-mg bolus, followed by a 90-mg intravenous infusio…

Adultmedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentVentricular Dysfunction RightPlacebolaw.inventionYoung AdultRandomized controlled trialDouble-Blind MethodFibrinolytic AgentslawInternal medicineFibrinolysismedicineHumansThrombolytic TherapyAgedFirst episodebusiness.industryHeparinAnticoagulantpulmonary embolism echocardiographyAnticoagulantsGeneral MedicineHeparinThrombolysisMiddle Agedmedicine.diseaseSurgeryPulmonary embolismEchocardiographyTissue Plasminogen ActivatorCardiologyWarfarinbusinessPulmonary Embolismmedicine.drugThe American journal of the medical sciences
researchProduct

Omega-3 polyunsaturated fatty acids: Benefits and endpoints in sport

2018

The influence of nutrition has the potential to substantially affect physical function and body metabolism. Particular attention has been focused on omega-3 polyunsaturated fatty acids (n-3 PUFAs), which can be found both in terrestrial features and in the marine world. They are responsible for numerous cellular functions, such as signaling, cell membrane fluidity, and structural maintenance. They also regulate the nervous system, blood pressure, hematic clotting, glucose tolerance, and inflammatory processes, which may be useful in all inflammatory conditions. Animal models and cell-based models show that n-3 PUFAs can influence skeletal muscle metabolism. Furthermore, recent human studies…

0301 basic medicineAntioxidantSettore MED/09 - Medicina InternaSports Nutritional Sciencesmedicine.medical_treatmentCellular functionslcsh:TX341-641InflammationReviewBioinformaticsOMEGA-3 POLYUNSATURATED FATTY ACIDS03 medical and health sciencesFatty Acids Omega-3medicineHumansExercisefunctional foodsNutritionSportchemistry.chemical_classificationInflammationOmega-3030109 nutrition & dieteticsNutrition and DieteticsHuman studiesbusiness.industrymarine bioactivesFunctional foodfood and beveragesSkeletal muscleMetabolismMarine bioactivemedicine.anatomical_structurechemistrySeafoodPUFAsmedicine.symptombusinesslcsh:Nutrition. Foods and food supplyPUFAFood SciencePolyunsaturated fatty acidHuman
researchProduct

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refr…

2000

Background: Diuretics, have been accepted as first-line treatment in refractory heart failure, but a lack of response is a frequent event. A randomised single blind study was performed to evaluate the effects of the combination of high-dose furosemide and small-volume hypertonic saline solution (HSS) infusion in the treatment of refractory NYHA class IV congestive heart failure (CHF). Materials and methods: Sixty patients (21 F/39 M) with refractory CHF (NYHA class IV) of different etiologies, unresponsive to high oral doses of furosemide, ACE-inhibitors, digitalis, and nitrates, aged 65–90 years, were enrolled. They had to have an ejection fraction (EF) < 35%, serum creatinine < 2 mg/dl, B…

Malemedicine.medical_specialtyDiuresisBlood PressurePotassium Chloridechemistry.chemical_compoundBolus (medicine)FurosemideHeart RateHumansMedicineSingle-Blind MethodDiureticsInfusions IntravenousAgedAged 80 and overHeart FailureSaline Solution HypertonicCreatinineEjection fractionbusiness.industryBody WeightSodiumFurosemideMiddle Agedmedicine.diseaseHypokalemiaDiuresisUric AcidSurgerychemistryCreatinineAnesthesiaHeart failurePotassiumDrug Therapy CombinationFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessHyponatremiamedicine.drugEuropean Journal of Heart Failure
researchProduct

851 Role of segmental and whole body bioelectrical impedance analysis (BIA) in acute heart failure diagnosis

2007

medicine.medical_specialtybusiness.industryHeart failureInternal medicinemedicineCardiologyCardiology and Cardiovascular MedicineWhole bodymedicine.diseasebusinessBioelectrical impedance analysisEuropean Journal of Heart Failure Supplements
researchProduct

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima–media thickness in female patients with active rheumatoid ar…

2009

The objective of the study is to evaluate the effect of TNF inhibition on carotid thickness over a 2-year period. 144 women with RA diagnosed according to ACR criteria, without clinical evidence of cardiac and/or vascular disease were enrolled and compared with 78 matched controls. All patients received methotrexate (15–20 mg weekly) for 3 months. Responders (n = 79) continued to be treated with methotrexate, non-responders (n = 40) moved to methotrexate plus a TNF alpha antagonist. Echosonographic studies of carotids were obtained before and after 2-year follow-up. A significant decrease of ca-IMT was observed in anti-TNF-treated patients (P < 0.001); on the other hand, no significant vari…

AdultCarotid Artery Diseasesmedicine.medical_specialtyImmunologyTNFGastroenterologyArthritis RheumatoidRheumatologyInternal medicineRheumatoid arthritis TNF DMARDs AtherosclerosisFemale patientmedicineHumansImmunology and AllergyRheumatoid arthritiUltrasonographyTumor Necrosis Factor-alphaVascular diseasebusiness.industryAntagonistMiddle AgedAtherosclerosismedicine.diseaseRheumatologySurgerySettore MED/16 - ReumatologiaDMARDMethotrexateTreatment OutcomeIntima-media thicknessAntirheumatic AgentsRheumatoid arthritiscardiovascular systemDrug Therapy CombinationFemaleMethotrexateTumor necrosis factor alphaTunica IntimaTunica Mediabusinessmedicine.drugRheumatology International
researchProduct

Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth facto…

2005

This study has been designed to evaluate the relationship among transforming growth factor beta1 (TGFbeta1) and some measurements of diastolic function in a population of hypertensive subjects with normal left ventricular ejection fraction. We studied 67 hypertensive outpatients who according to their BMI levels were subdivided into three groups: lean (L), overweight (OW) and obese (OB) hypertensives (HT). Circulating TGFbeta1 and M- and B-mode echocardiography was determined. All hypertensives were further subgrouped, according to European Society of Cardiology Guidelines, into two subsets of patients with normal diastolic function or with diastolic dysfunction. Prevalence of left ventricu…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart VentriclesEnzyme-Linked Immunosorbent Assayobesity-associated hypertension; TGFb1; left ventricular hypertrophy; left ventricular diastolic functionLeft ventricular hypertrophyTransforming Growth Factor beta1Ventricular Dysfunction LeftDiastoleRisk FactorsTransforming Growth Factor betaVentricule gaucheInternal medicineInternal MedicinemedicineHumansObesityOverproductionAgedbusiness.industryStroke VolumeNutritional statusMiddle Agedmedicine.diseaseMyocardial ContractionSettore MED/11 - Malattie Dell'Apparato CardiovascolareObesityEndocrinologyEchocardiographyHypertensionAdult Aged Biological Markers/blood Diastole Echocardiography Enzyme-Linked Immunosorbent Assay Female Heart Ventricles/physiopathology Heart Ventricles/ultrasonography Humans Hypertension/blood Hypertension/complications* Hypertension/physiopathology Hypertrophy Left Ventricular/blood Hypertrophy Left Ventricular/complications* Hypertrophy Left Ventricular/physiopathology Male Middle Aged Myocardial Contraction/physiology* Obesity/blood Obesity/complications* Obesity/physiopathology Regression Analysis Risk FactorsCardiologyRegression AnalysisFemaleHypertrophy Left VentricularbusinessVentricular fillingBiomarkersTransforming growth factorJournal of Human Hypertension
researchProduct

A new option in measuring bioimpedance in congestive heart failure

2009

We read with particular attention the interesting article of Tang and Tong1 concerning the measurement of impedance for assessing volume status in heart failure (HF). This technology is useful in detecting subclinical congestion and predicting future HF events.

medicine.medical_specialtyText miningbusiness.industrybioimpedance Heart FailureInternal medicineHeart failureCardiologyMedicineCardiology and Cardiovascular Medicinebusinessmedicine.disease
researchProduct

Rapid left ventricular filling in untreated hypertensive subjects with or without left ventricular hypertrophy

1992

In this study, independent contribution of age, HR, BMI, casual and ambulatory blood pressure, LVM and LVEF in evaluating diastolic filling have been investigated in 34 never-treated hypertensive patients and in 15 healthy normotensive subjects. All the subjects were free from coronary artery disease, valvular disease, heart failure, renal disease and psychiatric problems. All the hypertensive subjects (never treated) were subgrouped according to presence or absence of LVH. The PFR decreased significantly and tPFR increased significantly in hypertensive patients in comparison with normotensive subjects and they did not change in the presence vs absence of LVH. The PFR was inversely correlat…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAmbulatory blood pressureSettore MED/09 - Medicina InternaDiastoleBlood PressureCritical Care and Intensive Care MedicineLeft ventricular hypertrophyVentricular Function LeftBlood Pressure Echocardiography Female Humans Hypertension/complications Hypertension/physiopathology* Hypertension/radionuclide imaging Hypertension/ultrasonography Hypertrophy Left Ventricular/complications Hypertrophy Left Ventricular/physiopathology* Hypertrophy Left Ventricular/radionuclide imaging Hypertrophy Left Ventricular/ultrasonography Male Middle Aged Radionuclide Angiography Ventricular Function Left*Coronary artery diseaseInternal medicinemedicineHumanscardiovascular diseasesRadionuclide AngiographyEjection fractionbusiness.industryMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMean blood pressureEchocardiographyHeart failureHypertensionCardiologyEnd-diastolic volumeFemaleHypertrophy Left VentricularCardiology and Cardiovascular Medicinebusiness
researchProduct

Sudden severe abdominal pain after a single low dose of paracetamol/codein in a cholecystectomized patient: learning from a case report.

2009

We report the case of an elderly patient with diastolic heart failure and renal insufficiency admitted to hospital as he complained of having a history of hypogastric pain and dysuria without fever due to renal lithiasis and urinary infection. Because the pain was persistence, and considering the presence of renal dysfunction, it was administered a single low dose of paracetamol/codein (500/30 mg). After about 1 hour of the administration, he suddenly complained of the onset of a lancinating epigastric pain radiating to the whole abdomen and retrosternum accompanied by nausea. The electrocardiogram (EKG) was negative for myocardial infarction and computed tomography excluded aortic dissecti…

MaleSpasmmedicine.medical_specialtyAbdominal painmedicine.medical_treatmentabdominal pain paracetamolSeverity of Illness IndexEpigastric painSphincter of OddimedicineHumansDysuriaCholecystectomyPharmacology (medical)Sphincter of OddiContraindicationAcetaminophenAgedPharmacologyCodeinebusiness.industryGeneral MedicineAnalgesics Non-Narcoticmedicine.diseaseAbdominal PainSurgeryAnalgesics OpioidDrug CombinationsAcute abdomenAnesthesiaAcute pancreatitisCholecystectomymedicine.symptombusiness
researchProduct

Giant area of transient hepatic attenuation difference, mimicking incidentaloma at liver ultrasound.

2010

Concurrent with recent advances in diagnostic imaging techniques, the incidental finding of liver tumors, or incidentalomas, is increasing in asymptomatic and healthy individuals [1]. A 56-year-old healthy man underwent an abdomen ultrasound for a clinical check-up. A diffuse bright liver echo-pattern (indicating a low-moderate grade steatosis) and an unusual image (diameter approximately 10 cm) in the VI–VII hepatic segment, characterized by a massive giant hypoechoic lesion with poorly defined margins and a near rounded hyperechoic area (diameter about 4 cm) in the context were found (Fig. 1). The ultrasonographer suspected an angioma as first diagnostic hypothesis; however the large hypo…

Malemedicine.medical_specialtyContrast MediaContext (language use)AnastomosisAngiomaHemangiomaLesionInternal MedicinemedicineHumansVeinUltrasonographyIncidental Findingsgiant area ultrasoundbusiness.industryLiver DiseasesIncidentalomaLiver NeoplasmsFocal nodular hyperplasiaMiddle Agedmedicine.diseasemedicine.anatomical_structureLiverEmergency MedicineRadiologymedicine.symptomTomography X-Ray Computedbusiness
researchProduct

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refract…

2003

Background Diuretics have been accepted as first-line treatment in refractory congestive heart failure (CHF), but a lack of response to them is a frequent event. A randomized, single-blind study was performed to evaluate the effects of the combination of high-dose furosemide and small-volume hypertonic saline solution (HSS) infusion in the treatment of refractory New York Heart Association (NYHA) class IV CHF and a normosodic diet during follow-up. Materials and Methods One hundred seven patients (39 women and 68 men, age range 65-90 years) with refractory CHF (NYHA class IV) of different etiologies, who were unresponsive to high oral doses of furosemide, angiotensin-converting enzyme inhib…

Malemedicine.medical_specialtymedicine.medical_treatmentAdministration OralDrug Administration ScheduleBolus (medicine)FurosemideHeart rateMedicineHumansSingle-Blind MethodDiureticsInfusions IntravenousBlood urea nitrogenAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionDose-Response Relationship Drugbusiness.industryFurosemideSodium Dietarymedicine.diseaseSurvival AnalysisSurgeryTreatment OutcomeHeart failureAnesthesiaQuality of LifeFemaleDiureticCardiology and Cardiovascular MedicinebusinessHyponatremiamedicine.drugFollow-Up StudiesAmerican heart journal
researchProduct

Are BNP plasma levels useful in heart failure diagnosis each time? A dyspneic patient with anasarca.

2011

Heart FailureMalemedicine.medical_specialtyEdema Cardiacbusiness.industryBNP Heart FailureGeneral MedicinePlasma levelsMiddle Agedmedicine.diseaseAnasarcaDiagnosis DifferentialDyspneaHeart failureInternal medicineNatriuretic Peptide BrainEmergency MedicinemedicineCardiologyHumansmedicine.symptombusinessBiomarkersThe American journal of emergency medicine
researchProduct

Large hiatal hernia at chest radiography in a woman with cardiorespiratory symptoms

2012

Hiatal hernia (HH) is a frequent entity. Rarely, it may exert a wide spectrum of clinical presentations mimicking acute cardiovascular events such as angina-like chest pain until manifestations of cardiac compression that can include postprandial syncope, exercise intolerance, respiratory function, recurrent acute heart failure, and hemodynamic collapse. A 69-year-old woman presented to the emergency department complaining of fatigue on exertion, cough, and episodes of restrosternal pain with less than 1 hour of duration. Her medical history only included some episodes of bronchitis and no history of hypertension. The 12-lead electrocardiogram demonstrated sinus rhythm with right bundle-bra…

Chest Painmedicine.medical_specialtyBundle-Branch BlockChest painHiatal herniaElectrocardiographymedicine.arteryInternal medicinemedicineHumansRespiratory functionSinus rhythmmedicine.diagnostic_testbusiness.industryGeneral Medicinemedicine.diseaseRadiographyHernia HiatalHeart failurePulmonary arteryEmergency MedicineCardiologyFemaleRadiologymedicine.symptomTransthoracic echocardiogramEmergency Service HospitalbusinessElectrocardiographyThe American Journal of Emergency Medicine
researchProduct

Changes in natriuretic peptides and cytokines plasma levels in patients with heart failure, after high dose of furosemide plus small volume saline so…

2008

medicine.medical_specialtybusiness.industrySmall volumeFurosemidePlasma levelsmedicine.diseaseEndocrinologySaline solutionsInternal medicineAnesthesiaHeart failureInternal MedicinemedicineIn patientbusinessSaline loadingmedicine.drug
researchProduct

Obesity, hypertension and atherosclerosis

1993

Hypertension and obesity are associated with an increased risk of clinical cardiovascular complications due to atherosclerosis. Moreover has been reported that hypertension may predispose to atheroma development. In the present review some common aspects to hypertension and atherosclerosis including smooth muscle cell proliferation, endothelial damage and intervention of growth factors have been analyzed. Additional data have to be provided to explain if the connections between hypertension and atherosclerosis could be considered two effects with one unknown cause. In addition some aspects related to obesity and atherosclerosis have been dissected. In particular we have reported our results…

AdultMaleSettore MED/09 - Medicina InternaArteriosclerosisMyocardial InfarctionLipidsSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareBlood Coagulation FactorsObesity hypertension atherosclerosisRisk FactorsHypertensionPrevalenceHumansFemaleObesity
researchProduct

Arteriosclerosi ed artrite reumatoide: ruolo della terapia biologica

2005

researchProduct

Bioelectrical impedance parameters versus BNP testing to differentiate decompensated heart failure from chronic obstructive pulmonary disease.

2007

researchProduct

Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure

2000

Thirty patients aged 65-85 years, with refractory New York Heart Association (NYHA) class IV congestive heart failure (CHF) were treated with an intravenous infusion of furosemide (250-2000 mg/d) and small-volume hypertonic saline solution (150 mL of 1.4-4.6% NaCl) twice a day for 6 to 12 days. A daily fluid oral intake of 1000 mL and previous cardiac therapy were maintained. Clinical signs and symptoms of CHF, such as dyspnea, edema and weakness, improved, as did severity of illness as defined by NYHA class. The infusion was well tolerated. After a 12-month follow-up, 24 patients (80%) were alive and in the NYHA class assigned on discharge from the hospital. This therapeutic combination is…

Aged 80 and overHeart FailureMaleSaline Solution HypertonicAged; Aged 80 and over; Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions Intravenous; Italy; Male; Saline Solution Hypertonic; Statistics Nonparametric; Survival RateStatistics NonparametricSurvival RateItalyFurosemideDiureticHumansFemaleInfusions IntravenouDiureticsInfusions IntravenousHumanAged
researchProduct

Long-term effects on immune-inflammatory and neuro-endocrine pathways of a new therapeutic strategy for advanced heart failure

2007

researchProduct

The safety of diltiazem versus digoxin short-term administration in heart failure rate control of patients with atrial fibrillation and congestive he…

2008

researchProduct

Relationship between non-invasive measurement of endothelial function and familial hystory of cardiovascular event in hypertensives subjects of recen…

2007

researchProduct

Transforming growth factor ß1 ed effetto nefroprotettivo dell’associazione ACE-inibitore/ AT1 antagonista in soggetti ipertesi con iniziale danno ren…

2004

researchProduct

heart failure, after high dose of furosemide plus small volume saline solution (HSS) and after an acute saline loading

2007

researchProduct

EFFECT OF CANREONATE PLUS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN-CONVERTNG ENZYME INHIBITORS AOLNE ON SYSTOLIC AND DIASTOLIC FUN…

2005

researchProduct

Sindrome metabolica: fatti e compromessi.

2006

researchProduct

Cardiovascular Effects of I/D angiotension converting enzyme gene polymorphism in heathy subjects

2005

researchProduct

Echocardiographic PCWP evaluation in decompensated heart failure: relationship with B-type natriuretic peptide and bioelectrical impedance anaysis.

2007

researchProduct

The dry weight maintainance, estimated with bioelectrical impedance analysis, predicts freedom from congestion and post-discharge clinical outcome in…

2008

researchProduct

Non alcoholic liver steatosis asymptomatic carotid atherosclerosis and C-reactive protein in diabetic and non-diabetic patients.

2007

researchProduct

DIAGNOSTIC VALUE OF SEGMENTAL AND WHOLE BODY IMPEDANCE ANALYSIS IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH ACUTE DYSPNEA

2006

researchProduct

Steatosi epatica non-alcolica e aterosclerosi carotidea asintomatica in soggetti con e senza sindrome metabolica: uno studio caso-controllo

2008

researchProduct

acute coronary syndrome following large-volume paracentesis. Case report and pathophysiology

2006

researchProduct

Early ultrasonographic markers of atherosclerosis in adul white recent onset of primary hypertension and familial history of cardiovascular event

2007

researchProduct

Role of segmental and whole body bioelecttrical impedance analisys (BIA) in acute heart failure diagnosis

2007

researchProduct

Aterosclerosi e artrite reumatoide: ruolo della twerapia biologica

2005

researchProduct

Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazion…

2004

researchProduct

A case of febrile illness and multiple pulmonary embolism in a young woman acting hormonal contrapceptives.

2007

researchProduct

Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently…

2009

researchProduct

Athersoclerosis in females patients with rheumatoid arthritis: a two years follow-up

2005

researchProduct

Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor bl…

2006

Background: In this study the effects of 24 weeks losartan and ramipril treatment, both alone and in combination, on blood pressure and left ventricular mass (LVM) and function,have been evaluated in hypertensives. Methods. 57 hypertensives with stage 1 and 2 essential hypertension were included. After 4 weeks run in, a randomized double-blind, 3 arm, double dummy, independent trial was used. All patients were randomly allocated to 3 treatment arms consisting of losartan (50 mg/daily), ramipril (5 mg/daily), and combined (losartan 50 mg/ramipril 5 mg/daily) for 24 weeks. LVM, LVM/h and other echocardiographic measurements, BUN, creatinine and clearance and potassium were determined after ru…

Settore MED/09 - Medicina InternaAce-inhibitors Angiotensin II receptor blockers Left ventricular geometry and functionSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

Evaluation of BNP levels and bioelectrical impedance measurements after a novel therapy of refractory congestive heart failure

2005

researchProduct

Prevalence of obesity and ischaemic heart disease in hypertensive subjects

1997

In the present study the prevalence of obesity and its association with ischemic heart disease, recognized according to clinical criteria (chest pain or previous infarction) and/or instrumental data, were described in 8,847 normotensive subjects and in 867 hypertensive subjects, hospitalized during a ten years period (1983-1992), through a cross-sectional study. In view of this all the subjects were considered as lean or obese according to their body mass index (BMI) and to sex specific cut-off values reported in the Italian Consensus Conference on Obesity. In particular, according to BMI values, the subjects were grouped as lean, overweight, moderate and severe obese subjects. Our results …

AdultMaleSettore MED/09 - Medicina InternaMyocardial IschemiaObesity Hypertension Cardiovascular diseaseMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareItalyHypertensionHumansFemaleObesityAged
researchProduct

Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione…

2004

researchProduct

Intravenous high dose furosemide plus small volume of hypertonic saline solution (HSS) versus seriated paracentesis in treatment of refractory ascite…

2007

researchProduct

Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livel…

2005

researchProduct

Bioelectrical Impedance Analysis For Prediction Of Hospital Admission Due To Cardiac Decompensation In Ambulatory Heart Failure: A Follow-Up Study

2008

researchProduct

Biolectrical impedance analysis as a new diagnostic tool for heart failure diagnosis in parimary care: preliminary data

2007

researchProduct

Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects

1994

This study was designed to evaluate total (t) and surface (s) beta-adrenergic receptors (BAR) density and their relationships with left ventricular function in young obese subjects. BAR density, plasma insulin, catecholamines and left ventricular function were evaluated in 27 young obese subjects (BMI30.5 kg/m2 for males and27.3 kg/m2 for females) without other risk factors for cardiovascular diseases (smoking, hypertension, diabetes and lipid abnormalities) and in 20 lean controls (BMI25 kg/m2 for males and24.7 kg/m2 for females). Both groups were matched for gender, age and body height. BAR density was evaluated according to Böyum and De Blasi methods. Plasma catecholamines by high perfus…

AdultMaleAgingSettore MED/09 - Medicina InternaRadioimmunoassayPeripheral obesity Central Obesity lymphocyte beta adrenergic receptors left ventricular functionStroke VolumeSettore MED/11 - Malattie Dell'Apparato CardiovascolareVentricular Function LeftCatecholaminesEchocardiographyReceptors Adrenergic betaHumansInsulinRegression AnalysisFemaleLymphocytesObesityCardiac OutputRadionuclide AngiographyChromatography High Pressure Liquid
researchProduct

Sindrome Cardiorenale nello Scompenso Cardiaco cronico: fisiopatologia e terapia.

2008

researchProduct

Delayed facilitated percutaneous coronary intervention is better than immediate in reperfused myocardial infarction

2005

researchProduct

Atherosclerosis in females patients with rheumatoid arthritis; a two years follow-up.

2005

researchProduct

L’approccio al paziente con Scompenso Cardiaco

2008

researchProduct

L’ischemia critica

2007

ischemia critica
researchProduct

Whole-body and segmental bioelectrical impedance analyisis to predict rehospitalization due to worsening of congestive heart failure in anbulatory pa…

2007

researchProduct

Insufficienza renale inapparente nei soggetti anziani: correlazioni con l'impiego dei farmaci

2008

researchProduct

Is Bioelectrical Impedance Analysis Helpful for Heart Failure Management in the Emergency Department?

2008

researchProduct

Unusual case of recurrent pyrexia of unknown origin and cytopenia due to acute splenic sequestration crisis in a young patient with splenomegaly and …

2007

researchProduct

Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens

1996

Hypertension and central obesity are two conditions closely linked, but the mechanisms responsible for obesity-associated hypertension are still unclear. In the last few years, several studies addressed the role of endothelin-1 (ET-1) in the development and maintenance of hypertension. This study was designed to evaluate plasma ET-1 in normotensive and hypertensive central obese subjects compared with a lean healthy group. Our final goal was to analyze the relationship between plasma ET-1, blood pressure, and left ventricular structure and function in central obese subjects (both normotensives and hypertensives). ET-levels have been assessed by the radioimmunoassay method in 20 lean normote…

Settore MED/09 - Medicina InternaObesity central fat distribution hypertension endothelin.Settore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up

2005

researchProduct

Sindrome Metabolica

2006

researchProduct

Non-Invasive Detection Of PCWP In Decompensated Heart Failure Patients Treated With Intravenous High-Dose Furosemide And Small-Volume Hypertonic Sali…

2008

researchProduct

Intravenous high dose furosemide plus small volume of hypertonic saline solution (HSS) versus seriated paracentesis in treatment of refractory ascite…

2007

researchProduct

Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo. Eur J Clin Phar…

1993

In this study the efficacy and safety of short-term amlodipine administration on renal haemodynamics were evaluated in mild to moderate hypertensive subjects. Our final goal was to evaluate whether the reduced blood pressure induced by treatment was associated with maintenance of renal function. After a run-in period with placebo, 30 hypertensive patients without cardiac or renal diseases were randomly allocated to a double-blind 4 weeks controlled study with amlodipine 10 mg once a day (15 patients) or placebo (15 patients). Renal haemodynamic measurements included effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) by radionuclide study using 131I-hippuran and 99mTc, w…

Settore MED/14 - NefrologiaSettore MED/09 - Medicina InternaSettore BIO/14 - FarmacologiaAmlodipine hypertension renal haemodynamicsSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

Ultrasonography NAFLD subclinical carotid atherosclerosis and inflammatory markers in patients with and without metabolic syndome.

2007

researchProduct

ASSOCIAZIONE TRA HS-PCR E DIMENSIONI DELL'ATRIO SINISTRO IN IPERTESI MAI TRATTATI IN RITMO SINUSALE

2006

researchProduct

Relationship between ultrasonographic measurements of inferior vena cava and bioelectrical impedance analysis parameters in patients with decompensat…

2007

researchProduct

Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients

2007

The effects of 24 weeks losartan and ramipril treatment,both alone and in combination, on left ventricular mass (LVM), circulating transforming growth factor b1(TGFb1), procollagen type I (PIP) and III (PIIIP), havebeen evaluated in hypertensive (HT) patients. A total of 57 HT with stage 1 and 2 essential hypertension were included. After 4 weeks run in, a randomized double blind, three arms, double dummy, independent trial was used. All HT patients were randomly allocated to three treatment arms consisting of losartan (50 mg/daily),ramipril (5 mg/ daily) and combined (losartan 50 mg/daily plus ramipril 5 mg/daily) for 24 weeks. TGFb1, PIP and PIIIP, LVM, LVM/h 2.7 and other echocardiograph…

angiotensin II receptor blockertransforming growth factor b1left ventricular geometry and functionprocollagen type I and IIIace-inhibitor
researchProduct

Safwty of bioelectrical impedance analysis inevaluation of patient with liver chirrosis and relation with severity of disease

2007

researchProduct

Bioelectrical Impedance Analysis and prediction of hospitalization for heart failure in ambulatory patients with symptomatic left ventricular dysfunc…

2007

researchProduct

impedance analyisis to predict rehospitalization due to worsening of congestive heart failure in anbulatory patients

2007

researchProduct

Ultrasonography of the inferior vena cava and analysis of bioelectrical impedance in the assessment of decompensated heart failure.

2008

researchProduct

Role of segmental and whole body bioelectrical impedance analysis in acute heart failure diagnosis.

2007

Cardiovascular System & Cardiology Cardiac & Cardiovascular Systems
researchProduct

Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up

2005

researchProduct

Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno r…

2004

researchProduct